Dr. Mary Rensel, Curriculum Vitae

Dr. Mary Rensel is a Keynote speaker, business founder and Neuroimmunologist who is an expert in the neuroscience of joy and meaning at work.

CURRICULUM VITAE

Mary R Rensel

2024

PERSONAL INFORMATION

Name; last, first middle Rensel, Mary R

Credentials; MD, FAAN, ABIHM

Founder, Brain Fresh LLC

Neurologist since 1992

EDUCATION & TRAINING

Education

School & City, State / Country Gannon University Erie, PA

Degree BS, Biology

Start-End Dates 08/1984-05/1988

School & City, State / Country Medical College of Ohio, Toledo, OH

Degree MD

Start-End Dates 08/1988-05/1992

Post-Graduate Training

Institution & City, State / Country Cleveland Clinic Cleveland, OH

Position Internship

Start-End Dates 07/1992--06/1993

Institution & City, State / Country Cleveland Clinic

Position Resident, Neurology

Start-End Dates 07/1993-06/1996

Institution & City, State / Country Cleveland Clinic

Position Chief Resident, Neurology

Start-End Dates 07/1995-07/1996

Institution & City, State / Country Cleveland Clinic

Position Fellow, Neuroimmunology

Start-End Dates 07/1996-06/1998

PROFESSIONAL APPOINTMENTS

Position Staff, Director of Wellness and Pediatric MS, Mellen Center

Institution & Institute Cleveland Clinic, Neurologic Institute

Department Neurology

City, State / Country Cleveland, OH

Start-End Dates 05/2007-present

Position Associate Staff

Institution & Institute Cleveland Clinic, Neurologic Institute

Department Neurology

City, State / Country Cleveland, OH

Start-End Dates 02/2001-04/2007

Position Assistant Staff

Institution & Institute Cleveland Clinic, Neurologic Institute

City, State / Country Cleveland, OH

Start-End Dates 10/2000-01/2001

Position Clinical Associate

Institution & Institute Cleveland Clinic, Neurologic Institute

Department Neurology

City, State / Country Cleveland, OH

Start-End Dates 07/1998-09/2000

ACADEMIC APPOINTMENTS

Rank / Department Assistant Professor of Medicine

Institution & City, State / Country Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH

Start-End Dates 08/2016-present

Rank / Department Clinical Associate Professor

Institution & City, State / Country Cleveland Clinic Lerner College of Medicine of Case Western Reserve

Start-End Dates 02/2008-07/2016

Rank / Department Clinical Instructor

Institution & City, State / Country Cleveland Clinic Lerner College of Medicine of Case Western Reserve

Start-End Dates 02/2005-01/2008

ADDITIONAL CAREER DEVELOPMENT

Leadership Development

School / Institution National Association from Female Executives

Title / Certificate Leadership Summit

Start-End Dates 2014

School / Institution American Academy of Neurology

Title / Certificate Women in Advanced Leadership Roles

Start-End Dates 2015

School / Institution Cleveland Clinic

Title / Certificate Advanced Peer Coach training

Start-End Dates 2016

School / Institution American Academy of Neurology

Title / Certificate Advocacy Leadership training

Start-End Dates 2019

School / Institution Cleveland Clinic WPSA

Title / Certificate Women’s Leadership Retreat

Start-End Dates 09/2019

School / Institution EntreMD Business School

Title / Certificate EBS Graduate

Start-End Dates 06/2020-05/2021

School / Institution American College of Healthcare Executives

Title / Certificate ACHE member

Start-End Dates 03/2022-present

Educator Development

School / Institution Cleveland Clinic

Title / Certificate Master Educator Curriculum

Start-End Dates 01-10/2009

CERTIFICATION & LICENSURE

Certification

Name of Board American Board of Psychiatry and Neurology

Certificate Number 44154

Date Issued & Expires 1997-2027 (renewable 2027)

Name of Board American Board of Integrative Medicine

Certificate Number none

Date Issued & Expires 2008-present

Licensure

Name of State Medical Board Ohio

License Number 35068809

Date Issued & Expires 1995-2024

MEMBERSHIP IN PROFESSIONAL SOCIETIES

Name of Society American Academy of Neurology

Role / Title Member

Start-End Dates 1994-2019

Role / Title Fellow

Start-End Dates 2019- present

Name of Society American Medical Woman’s Association

Role / Title Member

Start-End Dates 1993- 1995, 2010, 2021-present

Name of Society The Academy of Medicine, Cleveland

Role / Title Member

Start-End Dates 2004, 2021, 2024

Name of Society American College of Healthcare Executives

Role / Title Member

Start-End Dates 2022-2023

Name of Society Ohio State Medical Association

Role / Title Member

Start-End Dates 2024

PROFESSIONAL SERVICES

Manuscript Reviewer

Journal 1 Multiple Sclerosis Journal

Start-End Dates 2015-present

Journal 2 International Journal of Multiple Sclerosis

Start-End Dates 2016-present

Journal 3 Multiple Sclerosis: Experimental, Translational and Clinical

Start-End Dates 2016-present

Journal 4 Neurology

Start-End Dates 2020-present

Study Sections

Organization American Academy of Neurology

Section / Committee Multiple Sclerosis study section

Section / Committee Neural Repair and Rehabilitation

Start-End Dates 2020-present

Section / Committee Neurointegrative section

Start-End Dates 2020-present

Section / Committee Women’s Issues in Neurology

Start-End Dates 2020-present

Advisory Groups

Organization National MS Society

Title Pediatric MS Study Group

Start-End Dates 2006-2009

Organization Pediatric MS Delphi Project

Title Co-Chair of Advisory Committee

Start-End Dates 2008-2011

Organization International Pediatric MS, Study Group

Title Clinical Trials Group

Start-End Dates 2011

Organization National MS Society, Ohio Chapter

Title Board Member

Start-End Dates 2019- present

Organization Biogen

Title Data Safety Monitoring Board

Start-End Dates 2020-2024

Organization Cleveland Clinic Neurological Institute

Title Leadership Advisory and Mentor

Start-End Dates 2021-2023

Administration

Organization Cleveland Clinic

Title Vice President, Women’s Professional Staff Association

Start-End Dates 01/2013-12/2016

Organization Cleveland Clinic

Title President, Women’s Professional Staff Association

Start-End Dates 01/2017-12/2018

Organization Cleveland Clinic

Title Past President, Women’s Professional Staff Association

Start-End Dates 01/2019-12/2020

COMMITTEE SERVICE

International

Organization: International Pediatric MS Study Group

Committee Name/Role: Member

Dates of service: 2014 -2023

Organization: International Pediatric MS Study Group

Committee Name/Role: Clinical trial committee member

Dates of service: 2017

Organization: International Women in Multiple Sclerosis

Committee Name/Role: Engagement Committee Member

Dates of Service: 07/2019- 2023

Organization: International Women in Multiple Sclerosis

Committee Name/Role: Pediatric MS Committee Member

Dates of Service: 07/2019- present

National

Organization: American Academy of Neurology

Committee Name/Role: Advocacy, Committee member

Dates of Service: 2021-present

Organization: Network of Pediatric MS Centers

Committee Name/Role: Steering Committee member

Dates of Service: 2015-present

Organization: Association of Reproductive Health Professionals

Committee Name/Role: Planning Committee

Dates of Service: 2017-2018

Organization: Accelerated Cure for MS

Committee Name/Role: Steering Committee member for our Patient/Participant-Driven Research initiative.

Dates of Service: 2019-2022

Cleveland Clinic

Committee Name/Role: MyChart Advisory, Member

Dates of Service: 2010-2012

Committee Name/Role: Women’s Professional Staff Association Career Development, member

Dates of Service: 2009-2014

Committee Name/Role: Women’s Professional Staff Association Education Committee, Chair

Dates of Service: 2013-2021

Committee Name/Role: 4 Quadrants Pilot Committee, member

Dates of Service: 2015

Committee Name/Role: Learning and Development Task Force, member

Dates of service: 2014- 2016

Committee Name/Role: Transitioning from Pediatric to Adult Care, member

Dates of Service: 2014-2016

Committee Name/Role: Office of Professional Staff Experience, member

Dates of Service: 2017

Committee Name/Role: Pediatric Institute Search, member

Dates of Service: 2017 - 2019

Committee Name/Role: Neurologic Institute Women’s Leadership development, member

Dates of Service: 2017 -present

Committee Name/Role: Conduct Review Task Force, member

Dates of Service: 2018

Committee Name/Role: Chaperone Policy Review Task Force, member

Dates of Service: 2018

Committee Name/Role: Executive Diversity Council, member

Dates of Service: 2018 –2019

Committee Name/Role: Women’s Professional Staff Association Podcast, Co-Director

Dates of Service: 2020 -2023

Educational Committees

Committee Name/Role: Learning and Development Task Force, member

Dates of service: 2014- 2016

Committee Name/Role: Women’s Professional Staff Association Biannual Meeting Planning, Member

Dates of Service: 2012-2017

Committee Name/Role: Women’s Professional Staff Association Biannual Meeting Planning, Chair

Dates of Service: 2017- 2018

HONORS & AWARDS

Clinical Neurology Award, Medical College of Ohio, 1992

Alumni of the Year, St. Francis of Assisi, 2003

Distinguished Educator Level I Certificate, Cleveland Clinic, 2007

Best Doctors of Cleveland, Cleveland Magazine, 2010 -present

Caregiver Celebration Award, Cleveland Clinic, 2013, 2014, 2020, 2021

Mentor Recognition Award, Cleveland Clinic, 2015

Service award for Career Development and Coaching, Cleveland Clinic, 2016

Outstanding preceptor for Medical students, Cleveland Clinic, 2019

Nominated, CCLCM Medical School Research Preceptor Award, 2022

Staff Recognition Award, Women in Neurologic Institute Training Council, Cleveland Clinic, 2022

TEACHING ACTIVITIES

Curriculum/ Course Development

Mellen Center Update 2015, Cleveland Clinic 09/2014-06/2015 Planning committee member, Course developer, Instructor, monthly meetings , 30 hours, regional healthcare workers

Consortium of MS Centers, 05/ 2015 and 06/2017 Women in Neurology Career Development, course development and instructor, 15 hours slide prep and monthly meetings , national course

Women in Health Care Forum, Cleveland Clinic, 2018 , Activity Director, Women’s Professional Staff Association, 50 hours, regional female staff

Neuromyelitis Optica Spectrum Disorder (NMOSD) Pediatric and Adult Patient and Caregiver Day, Cleveland Clinic, Activity Director, 2021 and 2022, 25 hours, national patient and caregivers

Neuromyelitis Optica Spectrum Disorder Pediatric and Adult Patient and Caregiver Day, Cleveland Clinic, Planning Committee, 2023, 202425 hours, national patient and caregivers

National Organization for Rare Disease Day (NORD) Day, Cleveland, OH Planning Committee, 10 hours, 2022, 2023, 2024

Cleveland Clinic Neuromyelitis Optica Spectrum Disorder and Myelin Ologodendrocyte Glycoprotein Associated Day, Cleveland, OH Planning Committee, 10 hours, 2024

Invited Lectures

International

Pediatric Multiple Sclerosis trials, International Pediatric MS Study Group (IPMSSG) Boston, MA 9/2014

Unique patterns in pediatric onset vs. adult onset Multiple Sclerosis, Global MS Paths Advisory Group 11/2020

Women in the Time of COVID, International Women in MS(IWIMS), 11/2020

Integrative Wellness in NMOSD, Cleveland Clinic NMOSD Virtual Global Symposium, October, 2023

National

The Clinical Impact of Therapies on MS Knoxville, TN, Consortium of MS Centers, 4/28/2005
Immunology of Multiple Sclerosis, Clinical Controversies Knoxville, TN Consortium of MS Centers 4/29/2005
Women in Leadership, Consortium of MS Centers (CMSC) Indianapolis, Indiana 05/2015
Wellness practices in General Neurology, Neurology Update, Washington, DC August 2015
Cleveland Clinic Pediatric MS Program, National meeting of Network of Pediatric MS Centers, Park City Utah 8/ 2015
Multiple Sclerosis and Women’s Health, Cleveland Clinic Vegas, Las Vegas, NV 9/2015
Multiple Sclerosis Care, Neurologist Perspective, Kansas City, Missouri 7/2016
Women in Leadership, Consortium of MS Centers (CMSC) New Orleans, La 2017
Using Your Patients as Resources: Group Medical Visits for Improved Wellness and Efficiency, American Academy of Neurology (AAN), Los Angeles, Ca 2018
Women in Leadership workshop, Consortium of MS Centers CMSC Nashville, TN 05/2018
Multiple Sclerosis Management Cases, National Cleveland Clinic Neurology Update, Cleveland Clinic, Washington, DC 08/2018
Wellness Shared Medical Visits, American Academy of Neurology AAN, Philadelphia, PA 042019
Reproductive Concerns in MS, Colorado Springs, Co 2/2019
Brain Health for the Professional Woman, Brave Enough CME Conference, Scottsdale Arizona, 9/2019
Complementary Alternative Medicine in MS, American Physician Institute, Women in Neurology Group, 10/ 2019
Wellness in Adult MS, Health Promotion and Wellness Multiple Sclerosis Association of America, National Virtual Webinar, 03/2020
Growing Pains, Transitioning from Pediatric to Adult MS, Health Promotion and Wellness Multiple Sclerosis Association of America, National Virtual Webinar, 08/2020
Amplifying and Extending Online Presence, American Academy of Neurology, PALF, Virtual, 11/2020
The How to and Why of a Shared Medical Appointment, American Academy of Neurology AAN NIN Section, Virtual 11/2020
New Day for Neuromyelitis Optica (NMOSD), Virtual, NMOSD Patient and Family Day, Virtual, March 11, 2021
Growing Pains, Transitioning from Pediatric to Adult MS, Health Promotion and Wellness Multiple Sclerosis Association of America, National Webinar, 08/2020
The Neuroimmunology of the Female Brain, University of California San Francisco UCSF, San Francisco, Ca, Virtual, March 2021
Time management and your Neuroscience, Virginia Commonwealth University, VCU, Richmond, VA September 2021
The Neuroimmunology of the Female Brain, October 2021 American Physician Institute, Women in Neurology Group, 09/2021
Post Stroke Care, Advocacy and Coaching, 13th Annual Practical Management of Stroke, Virtual, October, 2021
The Elevator Pitch, Consortium of MS Centers Orlando, FL October, 2021
Negotiation tactics, Consortium of MS Centers CMSC Orlando, FL October, 2021
How to start a Shared Medical Appointment (SMA) for MS, CMSC Consortium of MS Centers, Orlando, FL October, 2021
Multiple Sclerosis and Stress, CMSC Consortium of MS Centers, Orlando, FL October, 2021
The Shareholders of NMOSD Community, National Organization of Rare Diseases, Virtual, 02/2022
What is Neurology and why does one choose it in medical school, MOST fellows, Standford and CC, Virtual, 02/2022
The Neuroimmunology of Teams, American Healthcare Executives, Chicago, Il 03/2022
The Elevator Pitch, Consortium of Multiple Sclerosis Care, Baltimore, MD 05/2022
Negotiation tactics, Consortium of Multiple Sclerosis Care, Baltimore, MD 05/2022
Difficult Situations, Consortium of Multiple Sclerosis Care, Baltimore, MD 05/2022
Strategies to build a meaningful Wellbeing Plan while busy, stressed, and “lost” in the system, Keynote, State Illinois Neurologic Society Chicago, Il 09/2022
How to Navigate your Team dynamics Through Affinity Bias, Culture Building and Positive Conflict Resolution, American College of Heathcare Executives, Chicago, Il 03/2023
Navigating Burnout in Neuroimmunologic Healthcare workers, Virtual, National, MD Serono April, 2023
5 Minute Elevator Pitch and Networking, American Academy of Neurology, Boston, MA April, 2023
Networking for Women in Medicine, Consortium of Multiple Sclerosis Centers, Denver, Colorado May, 2023
Negotiation and Assertiveness training, Consortium of Multiple Sclerosis Centers, Denver, Colorado May, 2023
Sustainable Professional Wellbeing in Neurology, Virtual National, Women in Neurology CME Group, September 2023
Professional Wellbeing, Leadership Style, Sanofi Leadership retreat, Charlotte, North Carolina, September 2023
The neuroscience of team conflict, Virtual National, American College of Healthcare Executive Webinar, September, 2023
Nurse Wellbeing Toolkit, Visiting Nurse Association Virtual Webinar National, September, 2023.
Integrative Wellness in NMOSD, Guthy Jackson Foundation Patient Symposium, September, 2023
Networking and Negotiations for Women Neurologist, Women in Neurology Conference, Bonita Springs, FL November 2023
Audience Centered Presentation, Women Neurologist, Women in Neurology Conference, Bonita Springs, FL November 2023
Taking Neurology outside the office, Turning Advocacy into a career game changer, American Academy of Neurology Denver, CO April 2024
Women in Neurology: Building Skills for Thriving in Your Career, American Academy of Neurology Denver, CO April 2024
Emotional Intelligence for Brave Leadership, American Academy of Neurology Denver, CO April 2024
Leveraging your Social Media Network, American Academy of Neurology Denver, CO April 2024
Empowering Wellbeing in Multiple Sclerosis, Cleveland Clinic Vegas CME, Vegas, NV May 2024
Update on Inflammation in Multiple Sclerosis, the Complementary Medicine Focus, Consortium of Multiple Sclerosis Centers, Nashville, TN May 2024
Networking, Negotiations and Assertiveness for Women Neurologist, Consortium of Multiple Sclerosis Centers, Nashville, TN May 2024
Update on Inflammation in Multiple Sclerosis, the Complementary Medicine Focus, Women in Neurology, National Virtual, June 2024

Regional / Midwest

Fifth Annual Hot Topics in Neurology: Neurological Disorders of Women, Medical College of Ohio Toledo, OH, 5/18/2001
Multiple Sclerosis Challenges, Portage County MS Support Group Kent, OH 9/25/2001
MS, Scientific Updates 5/2003 Columbus, OH
New Medications for MS, Multiple Sclerosis Society of America, MSAA, Westlake, OH 5/2014
Reproductive Health in women with MS Fairlawn, OH 3/12/2015
Communication in MS Valley view, OH 5/2015
News on Nontraditional therapies for Multiple Sclerosis, Regional Mellen Center Update, 2016
MS Update, Patient program, Geneva, OH 2016
MS Update, Patient program, Geneva, OH 2017
MS Wellness Shared Medical Appointments, Regional Mellen Center Update, Cleveland, OH 06/2018
MS Breakthrough Keynote, Independence, OH December 14, 2019
MS Symptom Management and Wellness, Regional Mellen Center Update 2020, Cleveland, OH 06/2020
Brain Health and Mild Cognitive Impairment, Ohio American College of Physicians, Columbus, OH 10/2020
MS Care Review and Management, Regional Mellen Center Update 2021, Cleveland, OH 06/2021
Pediatric MS Clinical Trial Update, National MS Society Update, Virtual OH 11/2021
Caring for the Caregiver, Virtual Summit, 11/2022
Sustainable Well-Being for the Neurologist, Rush Medical Center, Chicago, Illinois, 07/2023
MS in the Young Adult, National Multiple Sclerosis Society Virtual Event, 04/2024

Local

Internal Medicine Noon Conference, New Diagnostic Criteria CCF 11/26/2002
Multiple Sclerosis, Scientific Update Cleveland, OH 10/2003
The Evolution of Diagnosing MS, New Consideration in Diagnostic Criteria Cleveland, OH 6/29/2002
Multiple Sclerosis, the Patient Perspective, National MS Society, Ohio Chapter March 2004
Pediatric MS: Neuropsychological Issues, Department of Neuropsychology Cleveland, OH 10/31/2005
Update on MS Therapies Cleveland, OH April, 2005
Neuropsychology in Pediatric MS, Neuropsychology Lecture Series, Department of Neuropsychology, Cleveland Clinic 2006
Existing and Emerging Topics in MS Cleveland, OH, Health space Cleveland, OH 4/29/2006
Management of Lifestyle Issues in Patients with MS Cleveland, OH 6/24/2006
MS Symptom Management, Mellen Center Regional Symposium on MS June 6th, 2008
Wellness in MS, National MS Society NMSS, Cleveland, OH 2009
Wellness in MS, Regional Mellen Center Update on MS, Cleveland, OH 6/2010
Wellness in MS, National MS Society NMSS, Cleveland, OH 10/2010
Nutrition and MS, National MS Society NMSS Cleveland, OH 10/2012
Pediatric MS, Cleveland Clinic Cleveland, OH 6/2013
Social Media for Professionals Women’s Professional Staff Association, WPSA Forum Cleveland, OH 9/2014
Newly Diagnosed MS, National MS Society, NMSS, Cleveland, OH 7/2014
WPSA Women in Health Care Forum Breakout session 09/2014
MS Care path, Cleveland Clinic, Foundation House CCF 5/5/2015
Update on AAN Guideline on CAM with MS, Mellen Center Update 06/2015
New and Emerging Therapies in MS, 6th Annual Pharmacology Course Cleveland, OH 11/2015
Multiple Sclerosis , Clinical basics, Cleveland Clinic residents, Cleveland, OH 2016
Multiple Sclerosis , Clinical basics, Cleveland Clinic residents, Cleveland, OH 2017
Immunology and MS Cleveland, OH 2017
What is MS, NMSS, Cleveland, OH 2017
Holy Grail, Health Brains in MS, MS World, Cleveland, OH 2017
Mind over Matter in MS, 1/11/2018 Cleveland, OH
Wellness in MS , 1/20/2018 Cleveland, OH
MS Therapies, NI Summit, Cleveland, OH March 2018
Women Leadership panel, Women in HVI retreat Cleveland, Oh 12/11/2018
Max your Melon, Brain Health for the Professional, WLCNEO Cleveland, OH September 2018
Pediatric MS, treatment updates, MS Update, Cleveland, OH March 2019
MS Pregnancy and Pediatric MS, fellows, Cleveland Clinic , 2019
MS & The Family: Working Towards A Healthy Lifestyle with MS, Multiple sclerosis association of America, Cleveland, OH 6/13/19
MS Care in the “Special” populations, Mellen Center Update Cleveland, OH June 2019
MS, pathology explained Cleveland , OH July, 2019
MS Updated disease modifying therapies, Cleveland, OH August 1,2019
MS Treatment Goals Cleveland , OH September 25, 2019
MS Path to Care Cleveland, OH November 2, 2019
Pediatric MS, fellows, Cleveland Clinic, 2020
Pediatric MS and ADEM, fellows, Cleveland Clinic, 2020
Women and Brain Health Key4Women Cleveland, Oh March 4, 2020
MS and Research Update Mellen research seminar series, January 11, 2021 Virtual
MS and career path, MOST fellows, Cleveland Clinic 2021
Pregnancy and Family Planning with a sprinkle of Wellness in MS, 2021, Cleveland Clinic
Brain Resiliency in the time of COVID, Cardinal , Cleveland, OH March 18, 2021
Social Networking for Professional Development, Neurologic Female Leaders Cleveland, Oh December 9, 2021
Navigating the Patriarchy, Women in Neurology Trainees, Cleveland, OH February 24, 2022
Audience Centered Presentations, Neurological Institute Leadership, Cleveland, OH November 10, 2022
Neurology Trainee Professional Well-Being Plan, Neurology Resident Lecture, Cleveland, OH January 13,2023
Introduction to Coaching Professional Well-Being for the residents, Cleveland, OH March, 2023
Social Networking, Neurological Institute Leadership, Cleveland, OH June 9, 2023
Comprehensive Wellness in MS, The Mellen Center Update, Cleveland, OH June, 2023
Networking for Neurologic Trainees, Cleveland Clinic Neurology Residents, August, 2023
Professional Wellbeing for the Gynecologist, Cleveland Clinic Gynecology Retreat, Beachwood, Ohio September, 2023
The neuroscience of Team Creativity, Advance Media Retreat, Cleveland, Ohio, September, 2023
Sustainable Wellbeing for the Women Doc, Internal medicine resident Coaching Retreat, Cleveland, Ohio April, 2024

Grand Rounds

National

Pediatric MS and Pharmacologic update on MS therapies ,University of Wisconsin, Madison, WI 10/2016
A New Day for NMOSD, University of Florida, Gainesville, FL 02/2021
WV Neuroimmunology of the Resilient Female Brain , West Virginia University Morgantown, WV 02/2021
Sustainable Well-Being for the Neurologist, University of Mississippi, 08/2023

Regional / Midwest

New and Emerging Therapies for MS, University Hospital health systems, Cleveland, OH 01/2017
Treatment strategies for MS, Metro Health, Cleveland, OH 02/2017
Pediatric MS Updates, University Hospital HS, Cleveland, OH 02/2018
Metro Health, Cleveland, OH Grand Rounds, Diagnosing MS, March 2018
University of Pittsburgh Pittsburgh, PA Neurologic Professional Well-Being Plan December, 2022

Local

Shared Medical Appointments in Neurology, Grand Rounds, Cleveland Clinic April 2018
Pediatric MS Update, Cleveland, OH Pediatric Neuropsychology Grand Rounds June 2016
University Health HS, Cleveland, OH Grand Rounds, New and Emerging Therapies for MS, January 2017
Metro Health, Cleveland, OH Grand Rounds, Treatment strategies for MS, February 2017
University Health HS, Cleveland, OH Grand Rounds, Pediatric MS , February 2018
Metro Health, Cleveland, OH Grand Rounds, Diagnosing MS, March 2018
Cleveland Clinic Hospital Medicine Grand Rounds Inpatient MS Care, what is new in 2019? September 2019
Cleveland Clinic Pediatric Epilepsy and Neuropsychology Grand Rounds, New Day for Pediatric NMO February 2021
Cleveland Clinic Neurology Grand Rounds, Overcoming Affinity Bias in Leadership Teams, September 2022

Visiting Professorships

Pediatric MS and Pharmacologic update on MS therapies, Resident lecture and Grand Rounds, University of Wisconsin, Madison, WI 10/2016

Other Presentations

International Research

Factors associated with Pediatric Onset Multiple Sclerosis slowed gait, does mood matter? European Congress of Treatment and Research in Multiple Sclerosis 2017 Paris, France M Rensel, Poster
Early age of onset predicts severity of visual impairment in patients with neuromyelitis optica, G. Macaron1, H. Li2, M. Seay3, J. Cohen1, M. Rensel, European Congress of Treatment and Research in Multiple Sclerosis 2018 Berlin, Germany, Poster
Assessing No Evidence of Disease Activity in Pediatric Onset Multiple Sclerosis

J. Feng1, B. Barney2, M. Waltz2, T.C. Casper2, M. Rensel1; 1Cleveland Clinic/Cleveland, OH/United States of America, 2University of Utah/Utah, UT/United States of America, American Committee on Treatment and Research in MS, ACTRIMS 9/2020 Virtual, Platform

National Research

Current Management of Symptomatic Vertebrobasilar Stenosis, American Academy of Neurology, Neurologists, Platform, Orlando, Florida,04/1996
Clinical experience with plasma exchange for severe relapse in patients with Devic's disease, American Academy of Neurology, Neurologist, Platform, San Diego, FL 04/2000
Association of Wellness practices in MS patients using Self-Reported Disability Scores and MS Characteristics, Platform, Consortium of Multiple Sclerosis Centers Indianapolis, In 5/2015
Correlating Blindness with Patient Reported Outcomes, Demographics, and Performance in NMO, Consortium of Multiple Sclerosis Centers, Platform, New Orleans, LA 5/2017
Factors associated with Pediatric Onset Multiple Sclerosis slowed gait, does mood matter? , Consortium of Multiple Sclerosis Centers, Platform, New Orleans, LA 05/2017

Local

Pediatric onset MS. A review of 60 cases., Yamamoto E, Ginsburg M, Rensel M, Moodley M, Presented at the Neurological Institute Research Day Meeting, Cleveland Clinic, Cleveland USA – May 2016 (presented)
Wellness in MS to Mellen Center fellow, Cleveland Clinic, Cleveland USA June 8, 2020
Pediatric MS to Mellen Center fellows annually
Neuroperformance and MRI measures predict quality of life in pediatric- and adult-onset multiple sclerosis, CCLCM Research Day, medical students, Student: Melissa Coronado , Mentor: Mary Rensel, MD 02/2022
Wellness in MS to Mellen Center fellow, Cleveland Clinic, Cleveland USA June 2021
Wellness in MS to Mellen Center fellow, Cleveland Clinic, Cleveland USA June 2022
Pregnancy in MS and NMO, Neurology residents, Cleveland Clinic, Cleveland USA August 2022
Professional Well-being in Neurology residents and fellows, Cleveland Clinic, Cleveland, OH USA January 2023

Trainees / Mentees

Robert Fox, MD, fellow at Mellen Center, years trained 2000-2002, now Staff at Cleveland Clinic
Ruth Anne Marrie, fellow at Mellen Center, years trained 2004-2006, now staff at University of Manitoba , Winnipeg, Manitoba, Canada, PhD
Natasha Frost, fellow at Mellen Center, year trained; 2006, now staff at University of Wisconsin
Myla Goldman, MD, fellow at Mellen Center, year trained; 2006, now Virginia Commonwealth U, Richmond, VA
Adrienne Boissy, MD, fellow at Mellen Center, years trained; 2006-2008, now staff at Cleveland Clinic
Robert Bermel, MD, fellow at Mellen Center, years trained; 2006-2008, now on staff at Cleveland Clinic
Devon Conway, MD, fellow at Mellen Center , years trained; 2009-2011, now staff at Cleveland Clinic
Mary Alissa Willis, fellow at Mellen Center , years trained; 2011-2012, now Chair at U Mississippi
Alex Sferra, MD, fellow at Mellen Center , years trained; 2013-2015, now staff at University Hospitals and VA
Dan Ontaneda, MD, fellow at Mellen Center, years trained; 2013-2015, now staff at Cleveland Clinic
Carrie Hersh, DO fellow at Mellen Center , years trained; 2013-2015, now Staff at Cleveland Clinic Vegas
Ian Rossman, MD, fellow at Mellen Center , years trained; 2014-2016, now staff at Akron Children’s
Hesham Abboud, fellow at Mellen Center , years trained; 2014-2016, now staff at University Hospitals
Andrew Smith, fellow at Mellen Center, years trained; 2015-2017,now staff at Ohio Health, Columbus, OH
Burhan Chaudry, fellow at Mellen Center, years trained; 2015-2017, uncertain.
Brandon Moss, fellow at Mellen Center, years trained; 2016-2018, now staff Cleveland Clinic
Marisa McGinley, fellow at Mellen Center , years trained; 2016-2018, now staff Cleveland Clinic
Kedar Mahajan, fellow at Mellen Center , years trained; 2016-2018, now staff Cleveland Clinic
Gabrielle Macaron, fellow at Mellen Center, years trained; 2017-2019, Adjunct Staff at Cleveland Clinic
Laura Baldaserri, fellow at Mellen Center, years trained; now staff at FDA
Ebtesam Alshehri, fellow at Mellen Center , years trained; 2018-2021, King Faisal Hospital in Jeddah
Jenny Feng, fellow at Mellen Center, years trained; 2018-2020, Staff New Orleans
Sam Cohn, fellow at Mellen Center, 2019, staff at Kaiser, Denver CO
Justin Abbatemarco, fellow at Mellen Center, 2019-2020, staff at Cleveland Clinic
Carolyn Goldschmidt, fellow at Mellen Center, 2019, Staff at Cleveland Clinic
Lindsay Ross, fellow at Mellen Center, 2020, staff at Cleveland Clinic
Chen Yan, fellow at Mellen Center, 2020-2021, Staff at Cleveland Clinic
Rose, Deja, fellow at Mellen Center, 2020, Staff at Emery
Simmons, Sarah, fellow at Mellen Center, 2020, Staff at Washington State University
Alise Carlson, MD, fellow at Mellen Center 2021- Cleveland Clinic Staff
Lisa Stropp, MD, fellow at Mellen Center 2022, University of Michigan, Ann Arbor, MI
Carrie Swetlik, MD fellow at Mellen Center, 2024 Metro Hospital Staff Cleveland, Ohio
Karlo Toljan, MD fellow at Mellen Center
Moen Amin, MD fellow at Mellen Center, 2024 Cleveland Clinic Staff
Kim DiMauro, MD fellow at Mellen Center,2024 Cleveland Clinic Staff

Teaching Activities

Woman in Health Care Forum, 9/14/2012 Women’s Professional Staff Association Biannual Meeting , committee member, monthly meetings, 15 hours, female staff regionally

Woman in Health Care Forum, 9/19/2014 Women’s Professional Staff Association Biannual Meeting , committee member, monthly meetings, 20 hours, female staff regionally

Women’s Professional Staff Association Representative Curriculum, 2014, committee member, monthly meetings, 20 hours, female staff

Women in Health Care Forum, 2016 , Women’s Professional Staff Association Biannual Meeting , committee member, monthly meetings, 20 hours, female staff

Teaching Learners Activities

Medical Student, Clinical Instructor and Case based Learning Facilitator , outpatient clinic

Hours of teaching per week 2-8

Year: 2006- 2020, 2022

Neurology Resident in outpatient clinic

Hours of teaching per week 4

Year: 2004-present

Neurology and Internal Medicine Resident inpatient wards q 3 months

Hours of teaching per week 50

Year: 2021-present

Neuroimmunology Fellow, outpatient clinic

Hours of teaching per week 4

Year: 2006-present

Woman’s Health resident , outpatient clinic

Hours of teaching per week 4

Year: 2005-2007

Summer High school intern, 8 weeks , clinic and research project

Year: 2012, 2013, 2015

Summer high school John Hay student, 3 weeks, outpatient clinic

Year: 2018, 2019

Summer Undergraduate student, 3 students, 12 weeks

Year: 2016, 2017, 2018 , 2022

Summer Medical students, outpatient clinic and research project

Year: 2017, 2018, 2022

Research Year Mentor to Cleveland Clinic Lerner College of Medicine Medical Student, guiding research project and outpatient clinic

Year: 2020 -2021

Mentor to Medical Observation and Scribe training (MOST) Fellow, scribe and research project

Year: 2020-2023

RESEARCH / GRANT SUPPORT

Granting agency: Inc Research Duration of grant: 2022-2026

Title: Operetta 2 PI: M Rensel, MD

Total Direct cost: 250,000 Salary Support: 3%

Granting agency: CC Educational Instit. Duration of grant: 2023-2024

Title: NI Trainee Well-being grant PI: M Rensel, MD

Total Direct cost: 20,000 Salary Support: 0%

Granting agency: NI CORE Duration of grant: 2020-2021

Title: Ped NEDA PI: M Rensel, MD

Total Direct cost: 10,000 Salary Support: 0%

Granting agency: Novartis Duration of grant: 2020

Title: Prevent Progression PI: M Rensel, MD

Total Direct cost: 26,600.00 Salary Support: 0%

Granting agency: Inc Research Duration of grant: 2020-2024

Title: Operetta 1 PI: M Rensel, MD

Total Direct cost: 250,000.00 Salary Support: 1%

Granting agency: UCSF Duration of grant: 2017-22

Title: Diet Study Ped MS PI: M Rensel, MD

Total Direct cost: 27,900.00 Salary Support: 1%

Granting agency: PPD Duration of grant: 2014-20

Title: Medimmune trial in NMO PI: M Rensel, MD

Total Direct cost: 197,000.00 Salary Support 0%

Granting agency: University of Utah Duration of grant: 2018-2024

Title: Pediatric MS Database PI: Mary Rensel, Aaron Abrams

Total Direct cost: 22,000.00 annually Salary Support: 10%

Granting agency: University of Utah Duration of grant: 2016-2022

Title: Pediatric MS Database, Coordinator PI: Mary Rensel, Aaron Abrams

Total Direct cost: 58,146.00 Salary Support 0%

Granting agency: Genzyme Duration of grant: 7/16-2022

Title: Wellness SMA for MS patients PI: Mary Rensel

Total Direct cost: 10,000.00 Salary Support 0%

Granting agency: Hospital for Sick Children Duration of grant: 9/14-9/16

Title: Adherence in Pediatric MS PI: Mary Rensel

Total Direct cost: 4,000.00 Salary Support: 1%

Granting agency: UCSF Duration of grant: 7/15-7/17

Title: Environment and Genetics in Pediatric MS/PI: Mary Rensel, Manikum Moodley

Total Direct cost: 25,000.00 Salary Support 1%

Clinical Trial Experience:

Site Co-PI Operetta 2, 2022- 2024
Site PI Operetta I 2019-2022
Site PI PPD study 2016-2020
Co PI in MS Promoting Wellness and Healthy Lifestyles 2020
PI in Pediatric MS NEDA project
Uncover mediators that may cause permeability of the blood brain barrier in relation to the microbiota. Co-investigator, 2017- present
Dietary Study in Ped MS, Site PI, 2017-2022
Environment and Genetic in Pediatric MS, PI, 2016- 2022
Network of Pediatric MS Center Co-PI ,2015-present
Compliance with Therapy in Pediatric MS PI, 2014-2015
A phase 2/3 Multicenter, randomized, double blind, placebo controlled study to evaluate the efficacy and safety of RPC1063 administered orally in MS patients. Examiner, 2015
Effect of Energy Therapy on Physiological Responses to Acute Stress Safety Committee Member, 2015
Neuroimaging Study of Tissue Integrity in placebo treated and Rituximab treated subjects with relapsing remitting MS U2787b sub study II MRI report reviewer, 2015
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab Examiner ,GATE: Multi-centre, randomized, double-blind, placebo-controlled, parallel-group, 9 month, equivalence trial comparing the efficacy and safety and tolerability of GTR (Synthon BV) to Copaxone® (Teva) in subjects with relapsing remitting multiple sclerosis followed by an open-label 15 month GTR treatment part evaluating the long-term GTR treatment effects. Examiner, 2015.
Phase 2/3 multicenter, randomized double blinded placebo controlled and double-blind double dummy active controlled parallel group study to evaluate the efficacy and safety of RPC1063 administered orally to relapsing MS patients. Examiner, 2015
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Subjects with Relapsing Multiple Sclerosis Examiner, 2014
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Subjects with Relapsing Multiple Sclerosis Examiner, 2014
Medimmune NMO trial, PI, 2014-2021
Randomized Treatment Interruption of Natalizumab Examiner, 2011
The effects of Meditation on pain, fatigue and physical functioning in patients with multiple sclerosis and peripheral neuropathy Co-investigator, 2009-2010
An Open-label, Multi-center, Extension Study to Evaluate the Safety and Tolerability of Natalizumab Following Re-Initiation of Dosing in Multiple Sclerosis Subjects Who Have Completed Study C-1801, C-1802 or C-1803 and a Dosing Suspension Safety Evaluation. Examiner, 2009
An Open-label, Multi-center, Extension Study to Evaluate the Safety and Tolerability of Natalizumab Following Re-Initiation of Dosing in Multiple Sclerosis Subjects Who Have Completed Study C-1801, C-1802 or C-1803 and a Dosing Suspension Safety Evaluation. Examiner, 2007
Tolerability of Interferon B1a in Children with MS Investigator 2006
Wadsworth Grant- Virology studies in Ped MS, Site PI, 2006
Pulse Cyclophosphamide Followed by Treatment with Avonex in Multiple Sclerosis Patients NonResponsive to Beta-interferons Examiner, 2003
IND#59730] A Multinational, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to

Evaluate the Efficacy, Tolerability and Safety of 2 Doses (5mg and 50mg) of Glatiramer Acetate Orally

Administered in Relapsing Remitting Multiple Sclerosis Patients (Protocol GA/7023) Examiner, 2002

A Randomized Study of Low fat Diet with Omega 3 Fatty Acid Supplementation in Patients with RR MS PI, 2001
A Randomized Study of Low fat Diet with Omega 3 Fatty Acid Supplementation in Patients with RR MS PI, 2001
T Cell Receptor Peptide Vaccine study in RR and Progressive MS Blinded examiner, 1998-1999
Oral Methotrexate Dose Escalation Study in Progressive MS Data Processor, 1998-2000

BIBLIOGRAPHY

Peer Reviewed Articles (Served as a mentor for those underlined)

Rensel, M., Weinstock-Guttman, B., Rudick, R., 1997. Devic’s disease: Diagnostic and therapeutic challenge. Multiple Sclerosis Journal 3, 408–408. https://doi.org/10.1177/135245...
Rensel, M., Kinkel, R.P., 1998. A 40-year-old woman with a “windmill” pattern of sensory disturbance. Cleve Clin J Med 65, 377–385.
Rensel, M., Cohen, J.A., 2000. The Current Approach to Managing MS. Women’s Health in Primary Care 3, 417–431.
Cohen, J., and M. Rensel. "The differential diagnosis and clues to misdiagnosis." Multiple sclerosis: Diagnosis, medical management and rehabilitation (2000): 127-138.
Waubant, E., Hietpas, J., Stewart, T., Dyme, Z., Herbert, J., Lacy, J., Miller, C., Rensel, M., Schwid, S., Goodkin, D., 2001. Interferon beta-1a in children with multiple sclerosis is well tolerated. Neuropediatrics 32, 211–213. https://doi.org/10.1055/s-2001...
Hahn, J., Pohl, D., Rensel, M., Rao, S., 2007. Differential Diagnosis and Evaluation in Pediatric MS. Neurology 68, S13-22.
Banwell, B., Krupp, L., Kennedy, J., Tellier, R., Tenembaum, S., Ness, J., Belman, A., Boiko, A., Bykova, O., Waubant, E., Mah, J.K., Stoian, C., Kremenchutzky, M., Bardini, M.R., Ruggieri, M., Rensel, M., Hahn, J., Weinstock-Guttman, B., Yeh, E.A., Farrell, K., Freedman, M., Iivanainen, M., Sevon, M., Bhan, V., Dilenge, M.-E., Stephens, D., Bar-Or, A., 2007. Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study. Lancet Neurol 6, 773–781. https://doi.org/10.1016/S1474-4422(07)70196-5
Tripathy, Moodley, Rensel, M., 2008. Childhood multiple sclerosis-Center based analysis of 22 cases. Neurology 70.
Banwell, B., Bar-Or, A., Cheung, R., Kennedy, J., Krupp, L.B., Becker, D.J., Dosch, H.-M., Wadsworth Pediatric Multiple Sclerosis Study Group, 2008. Abnormal T-cell reactivities in childhood inflammatory demyelinating disease and type 1 diabetes. Annals of Neurology 63, 98–111. https://doi.org/10.1002/ana.21244 (team contributor)
Hanaoka, B.Y., Libecco, J., Rensel, M., Hajj-Ali, R.A., 2008. Peripheral mononeuropathy with etanercept use: case report. J. Rheumatol. 35, 182.
McKeon, A., Lennon, V.A., Lotze, T., Tenenbaum, S., Ness, J.M., Rensel, M., Kuntz, N.L., Fryer, J.P., Homburger, H., Hunter, J., Weinshenker, B.G., Krecke, K., Lucchinetti, C.F., Pittock, S.J., 2008. CNS aquaporin-4 autoimmunity in children. Neurology 71, 93–100. https://doi.org/10.1212/01.wnl...
Le, N., Rensel, M., Moodley, M., 2009. Neuromyelitis optica: disease onset in relationship with infections and vaccinations.” J neurol 256, S54.
Bains, S.N., Hsieh, F.H., Rensel, M.R., Radojicic, C., Katz, H.T., Inamdar, S.R., Lang, D.M., 2010. Glatiramer acetate: successful desensitization for treatment of multiple sclerosis. Ann. Allergy Asthma Immunol. 104, 321–325. https://doi.org/10.1016/j.anai...
O’Connor, K.C., Lopez-Amaya, C., Gagne, D., Lovato, L., Moore-Odom, N.H., Kennedy, J., Krupp, L., Tenembaum, S., Ness, J., Belman, A., Boyko, A., Bykova, O., Mah, J.K., Stoian, C.A., Waubant, E., Kremenchutzky, M., Ruggieri, M., Bardini, M.R., Rensel, M., Hahn, J., Weinstock-Guttman, B., Yeh, E.A., Farrell, K., Freedman, M.S., Iivanainen, M., Bhan, V., Dilenge, M., Hancock, M.A., Gano, D., Fattahie, R., Kopel, L., Fournier, A.E., Moscarello, M., Banwell, B., Bar-Or, A., 2010. Anti-myelin antibodies modulate clinical expression of childhood multiple sclerosis. J. Neuroimmunol. 223, 92–99. https://doi.org/10.1016/j.jneu...
Tavee, J., Rensel, M., Planchon, S.M., Butler, R.S., Stone, L., 2011. Effects of meditation on pain and quality of life in multiple sclerosis and peripheral neuropathy: a pilot study. Int J MS Care 13, 163–168. https://doi.org/10.7224/1537-2...
Waldman, A.T., Gorman, M.P., Rensel, M.R., Austin, T.E., Hertz, D.P., Kuntz, N.L., Network of Pediatric Multiple Sclerosis Centers of Excellence of National Multiple Sclerosis Society, 2011. Management of pediatric central nervous system demyelinating disorders: consensus of United States neurologists. J. Child Neurol. 26, 675–682. https://doi.org/10.1177/088307...
Yeh, E.A., Grover, S.A., Powell, V.E., Alper, G., Banwell, B.L., Edwards, K., Gorman, M., Graves, J., Lotze, T.E., Mah, J.K., Mednick, L., Ness, J., Obadia, M., Slater, R., Waldman, A., Waubant, E., Schwartz, C.E., Rensel M Pediatric MS Adherence Study Group, 2017. Impact of an electronic monitoring device and behavioral feedback on adherence to multiple sclerosis therapies in youth: results of a randomized trial. Qual Life Res 26, 2333–2349. https://doi.org/10.1007/s11136...;
Lavery, A.M., Waldman, A.T., Charles Casper, T., Roalstad, S., Candee, M., Rose, J., Belman, A., Weinstock-Guttman, B., Aaen, G., Tillema, J.-M., Rodriguez, M., Ness, J., Harris, Y., Graves, J., Krupp, L., Benson, L., Gorman, M., Moodley, M., Rensel, M., Goyal, M., Mar, S., Chitnis, T., Schreiner, T., Lotze, T., Greenberg, B., Kahn, I., Rubin, J., Waubant, E., U.S. Network of Pediatric MS Centers, 2017. Examining the contributions of environmental quality to pediatric multiple sclerosis. Mult Scler Relat Disord 18, 164–169. https://doi.org/10.1016/j.msar...
Yeh, E.A., Grover, S.A., Powell, V.E., Alper, G., Banwell, B.L., Edwards, K., Gorman, M., Graves, J., Lotze, T.E., Mah, J.K., Mednick, L., Ness, J., Obadia, M., Slater, R., Waldman, A., Waubant, E., Schwartz, C.E., Pediatric MS Adherence Study Group, 2018. Correction to: Impact of an electronic monitoring device and behavioral feedback on adherence to multiple sclerosis therapies in youth: results of a randomized trial. Qual Life Res 27, 1117. https://doi.org/10.1007/s11136-017-1773-4 (team contributor)
Yamamoto, E., Ginsberg, M., Rensel, M., Moodley, M., 2018. Pediatric-Onset Multiple Sclerosis: A Single Center Study. J. Child Neurol. 33, 98–105. https://doi.org/10.1177/088307...
Schwartz, C.E., Grover, S.A., Powell, V.E., Noguera, A., Mah, J.K., Mar, S., Mednick, L., Banwell, B.L., Alper, G., Rensel, M., Gorman, M., Waldman, A., Schreiner, T., Waubant, E., Yeh, E.A., 2018. Risk factors for non-adherence to disease-modifying therapy in pediatric multiple sclerosis. Mult. Scler. 24, 175–185. https://doi.org/10.1177/135245...
Suleiman, L., Waubant, E., Aaen, G., Belman, A., Benson, L., Candee, M., Chitnis, T., Gorman, M., Goyal, M., Greenberg, B., Harris, Y., Hart, J., Kahn, I., Krupp, L., Lotze, T., Mar, S., Moodley, M., Ness, J., Nourbakhsh, B., Rensel, M., Rodriguez, M., Rose, J., Rubin, J., Schreiner, T., Tillema, J.-M., Waldman, A., Weinstock-Guttman, B., Casper, T.C., Waltz, M., Graves, J.S., Network of Pediatric Multiple Sclerosis Centers., 2018. Early infectious exposures are not associated with increased risk of pediatric-onset multiple sclerosis. Mult Scler Relat Disord 22, 103–107. https://doi.org/10.1016/j.msar...
Lavery, A.M., Waubant, E., Casper, T.C., Roalstad, S., Candee, M., Rose, J., Belman, A., Weinstock-Guttman, B., Aaen, G., Tillema, J.-M., Rodriguez, M., Ness, J., Harris, Y., Graves, J., Krupp, L., Charvet, L., Benson, L., Gorman, M., Moodley, M., Rensel, M., Goyal, M., Mar, S., Chitnis, T., Schreiner, T., Lotze, T., Greenberg, B., Kahn, I., Rubin, J., Waldman, A.T., 2018. Urban air quality and associations with pediatric multiple sclerosis. Ann Clin Transl Neurol 5, 1146–1153. https://doi.org/10.1002/acn3.6...
Nourbakhsh, B., Rutatangwa, A., Waltz, M., Rensel, M., Moodley, M., Graves, J., Casper, T.C., Waldman, A., Belman, A., Greenberg, B., Goyal, M., Harris, Y., Kahn, I., Lotze, T., Mar, S., Schreiner, T., Aaen, G., Hart, J., Ness, J., Rubin, J., Tillema, J.-M., Krupp, L., Gorman, M., Benson, L., Rodriguez, M., Chitnis, T., Rose, J., Candee, M., Weinstock-Guttman, B., Shao, X., Barcellos, L., James, J., Waubant, E., US Network of Pediatric MS Centers, 2018. Heterogeneity in association of remote herpesvirus infections and pediatric MS. Ann Clin Transl Neurol 5, 1222–1228. https://doi.org/10.1002/acn3.6...
Krysko, K.M., Graves, J., Rensel, M., Weinstock-Guttman, B., Aaen, G., Benson, L., Chitnis, T., Gorman, M., Goyal, M., Krupp, L., Lotze, T., Mar, S., Rodriguez, M., Rose, J., Waltz, M., Charles Casper, T., Waubant, E., US Network of Pediatric MS Centers, 2018. Use of newer disease-modifying therapies in pediatric multiple sclerosis in the US. Neurology 91, e1778–e1787. https://doi.org/10.1212/WNL.00...
Mar, S., Liang, S., Waltz, M., Casper, T.C., Goyal, M., Greenberg, B., Weinstock-Guttman, B., Rodriguez, M., Aaen, G., Belman, A., Barcellos, L.F., Rose, J., Gorman, M., Benson, L., Candee, M., Chitnis, T., Harris, Y., Kahn, I., Roalsted, S., Hart, J., Lotze, T., Moodley, M., Ness, J., Rensel, M., Rubin, J., Schreiner, T., Tillema, J.-M., Waldman, A., Krupp, L., Graves, J.S., Waubant, E., U.S. Network of Pediatric Multiple Sclerosis Centers, 2018. Several household chemical exposures are associated with pediatric-onset multiple sclerosis. Ann Clin Transl Neurol 5, 1513–1521. https://doi.org/10.1002/acn3.6...
Aaen, G., Waltz, M., Vargas, W., Makhani, N., Ness, J., Harris, Y., Casper, T.C., Benson, L., Candee, M., Chitnis, T., Gorman, M., Graves, J., Greenberg, B., Lotze, T., Mar, S., Tillema, J.-M., Rensel, M., Rodriguez, M., Rose, J., Rubin, J., Schreiner, T., Waldman, A., Weinstock-Guttman, B., Belman, A., Waubant, E., Krupp, L., 2018. Acquisition of Early Developmental Milestones and Need for Special Education Services in Pediatric Multiple Sclerosis. J. Child Neurol. 883073818815041. https://doi.org/10.1177/088307...
Chi, C., Shao, X., Rhead, B., Gonzales, E., Smith, J.B., Xiang, A.H., Graves, J., Waldman, A., Lotze, T., Schreiner, T., Weinstock-Guttman, B., Aaen, G., Tillema, J.-M., Ness, J., Candee, M., Krupp, L., Gorman, M., Benson, L., Chitnis, T., Mar, S., Belman, A., Casper, T.C., Rose, J., Moodley, M., Rensel, M., Rodriguez, M., Greenberg, B., Kahn, L., Rubin, J., Schaefer, C., Waubant, E., Langer-Gould, A., Barcellos, L.F., 2019. Admixture mapping reveals evidence of differential multiple sclerosis risk by genetic ancestry. PLoS Genet. 15, e1007808. https://doi.org/10.1371/journa...
Smith, A. L., Cohen, J. A., Ontaneda, D., & Rensel, M. (2019). Pregnancy and multiple sclerosis: Risk of unplanned pregnancy and drug exposure in utero. Multiple Sclerosis Journal–Experimental, Translational and Clinical, 5(4), 2055217319891744.
Rensel M, 2019, Long term Treatment strategies of Pediatric Multiple Sclerosis, Including the use of disease modifying therapies, Children 2019, 6(6), 73; https://doi.org/10.3390/childr...
Feng J, Rensel M, Review of the safety, efficacy and tolerability of fingolimod in Pediatric onset MS, 12 November 2019 Volume 2019:10 Pages 141—146, Pediatric Health, Medicine and Therapeutics. https://doi.org/10.2147/PHMT.S...
Macaron G, Moss BP, Li H, Baldassari LE, Rao SM, Schindler D, Alberts JL, Weber M, Ayers M, Bethoux F, Boissy A, Chizmadia D, Conway DS, Fink C, Fox RJ, Gales S, Green B, Hara-Cleaver C, Jordan N, Mahajan KR, McGinley MP, Miller DM, Namey M, Rae-Grant A, Rensel M, Young H, Willis MA, Ontaneda D, Cohen JA, Bermel RA. Technology-enabled assessments to enhance multiple sclerosis clinical care and research. Neurol Clin Pract Jun 2020, 10 (3) 222-231; DOI: 10.1212/CPJ.0000000000000710
Macaron G, Feng J, Moodley M, Rensel M Newer Treatment Approaches in Pediatric- Onset Multiple Sclerosis. Curr Treat Options Neurol. 2019 Sep 27;21(10):50. doi: 10.1007/s11940-019-0592-z
Wallach, Asya I, Michael Waltz, T Charles Casper, Gregory Aaen, Anita Belman, Leslie Benson, Tanuja Chitnis, Mark Gorman, Yolanda Harris, Timothy Lotke, Soe Mar, Manikum Moodley, Jayne Ness, Mary Rensel, Moses Rodriquez, John Rose, Teri Schreiner, Jan Mendelt-Tillema, Emmanuelle Waubant, Bianca Weinstock Guttman, Lauren Krupp , on behalf of the US Network of Pediatric Multiple Sclerosis Centers, Cognitive Processing Speed in Pediatric-Onset Multiple Sclerosis: Baseline Characteristics of Impairment and Prediction of Decline.” Multiple Sclerosis Journal. 2020; 26(14):1938-1947. doi:10.1177/1352458519891984
Krysko, K.M., Graves, J.S., Rensel, M., Weinstock-Guttman, B., Rutatangwa, A., Aaen, G., Belman, A., Benson, L., Chitnis, T., Gorman, M., Goyal, M.S., Harris, Y., Krupp, L., Lotze, T., Mar, S., Moodley, M., Ness, J., Rodriguez, M., Rose, J., Schreiner, T., Tillema, J.-M., Waltz, M., Casper, T.C., Waubant, E. and (2020), Real-World Effectiveness of Initial Disease-Modifying Therapies in Pediatric Multiple Sclerosis. Ann Neurol, 88: 42-55. https://doi.org/10.1002/ana.25...
Tanuja Chitnis, Greg Aaen, Anita Belman, Leslie Benson, Mark Gorman, Manu S Goyal, Jennifer S Graves, Yolanda Harris, Lauren Krupp, Timothy Lotze, Soe Mar, Jayne Ness, Mary Rensel, Teri Schreiner, Jan-Mendelt Tillema, Emmanuelle Waubant, Bianca Weinstock-Guttman, Shelly Roalstad, John Rose, Howard L Weiner, T Charles Casper, Moses Rodriguez, for the US Network of Paediatric Multiple Sclerosis Centers, Improved relapse recovery in paediatric compared to adult multiple sclerosis, Brain, Volume 143, Issue 9, September 2020, Pages 2733–2741, https://doi.org/10.1093/brain/...
Spurgeon E Abbatemarco J Rensel M a Case of Severe Legionella Pneumonia following Alemtuzumab Infusion for Multiple Sclerosis. Clinical Neurology and Neurosurgery 196 (2020) 105961
JonathanD. Santoro, Michael Waltz, Greg Aaen, Anita Belman, Leslie Benson, Mark Gorman, Manu S. Goyal, JenniferS. Graves, Yolanda Harris, Lauren Krupp, Timothy Lotze, Soe Mar, Manikum Moodley, Jayne Ness, Mary Rensel, Moses Rodriguez, Teri Schreiner, Jan-Mendelt Tillema, Emmanuelle Waubant, Bianca Weinstock-Guttman, Brigitte F. Hurtubise, Shelly Roalstad, John Rose, T. Charles Casper, Tanuja Chitnis, the US Network of Pediatric MS Centers. Pediatric Multiple Sclerosis Severity Score in a large US cohort.Neurology Sep 2020, 95 (13) e1844-1853; DOI: 10.1212/WNL.0000000000010414
Schreiner, T.; Chitnis, T.; Tillema, J. M.; Benson, L.; Gorman, M.; Goyal, M.; Harris, Y.; Krupp, L.; Lotze, T.; Mar, S.; Ness, J.; Rensel, M.; Rodriguez, M.; Shukla, N.; Waubant, E.; Rose, J.; Roalstad, S.; Casper, T. C.. Demographic and clinical profile of pediatric patients with multiple sclerosis infected with sars-cov2.Multiple Sclerosis Journal; 26(3 SUPPL):90-91, 2020.
J.R. Abbatemarco, J.Hartman, M, McGinley, R.A. Bermel, A. Boissy, D. Chizmadia, A.B. Sullivan, M. R. Rensel. “Providing Person Centered Care via Telemedicine in the Era of COVID-19 in Multiple Sclerosis ” J Patient Exp https://doi.org/10.1177/237437...
Gabrielle Macaron, Jean Khoury, James Bena, Meagan Seay, Robert A Bermel, Jeffrey A Cohen, Mary R Rensel. Early age of onset predicts severity of visual impairment in patients with neuromyelitis optica spectrum disorder. Multiple Sclerosis J(13524585), January 2021
BE Davis, L Lakin, CC Binns, KM Currie, MR Rensel Patient and Provider Insights into the Impact of Multiple Sclerosis on Mental Health: A Narrative Review ,Neurology and Therapy, 20 Apr 2021, 10(1):99-119
Lynsey Lakin, Bryan E Davis, Cherie C Binns, Keisha M Currie, Mary R Rensel Comprehensive Approach to Management of Multiple Sclerosis: Addressing Invisible Symptoms—A Narrative Review. Neurol Ther 10, 75–98 (2021). https://doi.org/10.1007/s40120...
Justin R. Abbatemarco, Jeffrey A. Cohen, Belinda L. Udeh, Sunakshi Bassi, Mary R. Rensel; Multiple Sclerosis Wellness Shared Medical Appointment Model: A Pilot Study. Int J MS Care 2021; doi: https://doi.org/10.7224/1537-2...
Jalkh, G.; Abi Nahed, R.; Macaron, G.; Rensel, M. Safety of Newer Disease Modifying Therapies in Multiple Sclerosis. Vaccines 2021, 9, 12. https://doi.org/10.3390/vaccin...
Mary K. Horton, Kathryn McCauley, Douglas Fadrosh, Kei Fujimura, Jennifer Graves, Jayne Ness, Yolanda Wheeler, Mark P. Gorman, Leslie A. Benson, Bianca Weinstock-Guttman, Amy Waldman, Moses Rodriguez, Jan-Mendelt Tillema, Lauren Krupp, Anita Belman, Soe Mar, Mary Rensel, Tanuja Chitnis, Theron Charles Casper, John Rose, Janace Hart, Xiaorong Shao, Helen Tremlett, Susan V. Lynch, Lisa F. Barcellos, Emmanuelle Waubant, the U.S. Network of Pediatric MS Centers. Gut microbiome is associated with multiple sclerosis activity in children, 8/19/2021 Annals of Clinical and Translational Neurology, https://doi.org/10.1002/acn3.5...
Rensel M, Zabeti A, Mealy MA, et al. Long-term efficacy and safety of inebilizumab in neuromyelitis optica spectrum disorder: Analysis of aquaporin-4–immunoglobulin G–seropositive participants taking inebilizumab for ⩾4 years in the N-MOmentum trial. Multiple Sclerosis Journal. October 2021. doi:10.1177/13524585211047223
Familial History of Autoimmune Disorders Among Patients With Pediatric Multiple Sclerosis. Benjamin M. Greenberg, Theron Charles Casper, Soe S. Mar, Jayne M. Ness, Patricia Plumb, Shannon Liang, Manu Goyal, Bianca Weinstock-Guttman, Moses Rodriguez, Gregory S. Aaen, Anita Belman, Lisa F. Barcellos, John W. Rose, Mark P. Gorman, Leslie A. Benson, Meghan Candee, Tanuja Chitnis, Yolanda C. Harris, Ilana L. Kahn, Shelly Roalstad, Janace Hart, Timothy E. Lotze, Mary Rensel, Jennifer P. Rubin, Teri L. Schreiner, Jan-Mendelt Tillema, Amy Tara Waldman, Lauren Krupp, Jennifer Graves, Kaylea Drake, Emmanuelle Waubant. Neurol Neuroimmunol Neuroinflamm Sep 2021, 8 (5) e1049; DOI: 10.1212/NXI.0000000000001049
Ziaei A, Lavery AM, Shao XM, Amin Ziaei, Amy M Lavery, Xiaorong MA Shao, Cameron Adams, T Charles Casper, John Rose, Meghan Candee, Bianca Weinstock-Guttman, Greg Aaen, Yolanda Harris, Jennifer Graves, Leslie Benson, Mark Gorman, Mary Rensel, Soe Mar, Tim Lotze, Benjamin Greenberg, Tanuja Chitnis, Janace Hart, Amy T Waldman, Lisa F Barcellos, Emmanuelle WaubantOn Behalf of the US Network of Pediatric MS Centers, Gene–environment interactions increase the risk of pediatric-onset multiple sclerosis associated with ozone pollution. Multiple Sclerosis Journal. January 2022. doi:10.1177/13524585211069926
Lindsay Ross, Catherine Hassett, Peter Brown, Elizabeth Spurgeon, Rachael Mathew, Gabriella Bal, Muhammad Shazam Hussain, Amarilis Martin, Julie K. Silver, Mary Rensel

Neurology Jun 2022, 10.1212/WNL.0000000000200567; DOI: 10.1212/WNL.0000000000200567

Recommendations to Address the Unique Clinical and Psychological Needs of Transgender Persons Living With Multiple Sclerosis . Amy Sullivan, PsyD; Alexa Kane, PsyD; Gianna Valentic, BA; Mary Rensel, MD, Int J MS Care (2022) 24 (1): 35–40.,https://doi.org/10.7224/1537-2...
Sabsabi, S., Mikhael, E., Jalkh, G., Macaron, G. and Rensel, M., 2022. Clinical Evaluation of Siponimod for the Treatment of Secondary Progressive Multiple Sclerosis: Pathophysiology, Efficacy, Safety, Patient Acceptability and Adherence. Patient preference and adherence, 16, p.1307.
Aaron W Abrams, Amanda March, Daphne Porat, Kriti Bhayana, Mary Rensel Published Online: June 22nd 202@, touch.REVIEWS in Neurology. 2022;18(1):42–8
Gaudioso, C.M., Mar, S., Casper, T.C., Codden, R., Nguyen, A., Aaen, G., Benson, L., Chitnis, T., Francisco, C., Gorman, M.P., Goyal, M.S., Graves, J., Greenberg, B.M., Hart, J., Krupp, L., Lotze, T., Narula, S., Pittock, S.J., Rensel, M., Rodriguez, M., Rose, J., Schreiner, T., Tillema, J.-M., Waldman, A., Weinstock-Guttman, B., Wheeler, Y., Waubant, E., Flanagan, E.P. and (2022), MOG and AQP4 Antibodies among Children with Multiple Sclerosis and Controls. Ann Neurol. https://doi.org/10.1002/ana.26502
Lauren B Krupp,,Emmanuelle Waubant, Michael Waltz, T

Charles Casper, Anita Belman, Yolanda Wheeler, Jayne Ness, Jennifer Graves, Mark Gorman, Leslie Benson, Soe Mar, Manu Goyal, Teri Schreiner, Bianca Weinstock-Guttman , Moses Rodriguez, Jan-Mendelt Tillema, Timothy Lotze, Greg Aaen, Mary Rensel , John Rose, Tanuja Chitinis , Allan George, Leigh E Charvet, A new look at cognitive functioning in pediatric MS. Multiple Sclerosis Journal. 2023;29(1):140-149. doi:10.1177/13524585221123978

Raffaella Pizzolato Umeton, Michael Waltz, Gregory S Aaen, Leslie Benson, Mark Gorman, Manu Goyal, Jennifer S. Graves, Yolanda Harris, Lauren Krupp, Timothy E. Lotze, Nikita M. Shukla, Soe Mar, Jayne Ness, Mary Rensel, Teri Schreiner, Jan-Mendelt Tillema, Shelly Roalstad, Moses Rodriguez, John Rose, Emmanuelle Waubant, Bianca Weinstock-Guttman, Charles Casper, Tanuja Chitnis,Therapeutic Response in Pediatric Neuromyelitis Optica Spectrum Disorder. Neurology. 2022 Dec 2.
Nasr Z, Schoeps VA, Ziaei A, Virupakshaiah A, Adams C, Casper TC, Waltz M, Rose J, Rodriguez M, Tillema JM, Jennifer S Graves, Leslie Benson, Mary Rensel, Lauren Krupp, Amy T Waldman, Bianca Weinstock-Guttman, Tim Lotze, Benjamin Greenberg, Gregory Aaen, Soe Mar, Teri Schreiner, Janace Hart, Steve Simpson-Yap,Clementina Mesaros, Lisa F Barcellos, Emmanuelle Waubant.Gene–environment interactions increase the risk of paediatric-onset multiple sclerosis associated with household chemical exposures. Journal of Neurology, Neurosurgery & Psychiatry. 2023 Feb 1.
Sullivan, A.B., Hersh, C.M., Rensel, M. et al. Leadership Inequity, Burnout, and Lower Engagement of Women in Medicine. J Health Serv Psychol (2023). https://doi.org/10.1007/s42843-023-00078-9
Toljan, K., Mahadeen, A., Amin, M., Rensel, M., Jones, S. E., Ontaneda, D., & Kunchok, A. C. (2023). Pearls & Oy-sters: Hemorrhagic Myelitis Following SARS-CoV-2 Infection. Neurology.
Schreiner T, Wilson-Murphy M, Mendelt-Tillema J, et al. Characteristics of pediatric patients with multiple sclerosis and related disorders infected with SARS-CoV-2. Multiple Sclerosis Journal. 2023;0(0). doi:10.1177/13524585231151948
Carlson, A. K., Ontaneda, D., Rensel, M. R., Cohen, J. A., & Kunchok, A. (2023). Reproductive issues and multiple sclerosis: 20 questions. Cleveland Clinic journal of medicine, 90(4), 235-243.
Vikram Bhise, Michael Waltz, T. Charles Casper, Gregory Aaen, Leslie Benson, Tanuja Chitnis, Mark Gorman, Manu S. Goyal, Yolanda Wheeler, Timothy Lotze, Soe Mar, Mary Rensel, Aaron Abrams, Moses Rodriguez, John Rose, Teri Schreiner, Nikita Shukla, Emmanuelle Waubant, Bianca Weinstock-Guttman, Jayne Ness, Lauren Krupp, Jan Mendelt-Tillema,Silent findings: Examination of asymptomatic demyelination in a pediatric US cohort,Multiple Sclerosis and Related Disorders,Volume 71,2023,104573,ISSN 2211-0348,https://doi.org/10.1016/j.msar....
Horton MK, Shim JE, Wallace A, et al. Rare and low-frequency coding genetic variants contribute to pediatric-onset multiple sclerosis. Multiple Sclerosis Journal. 2023;0(0). doi:10.1177/13524585221150736
Conway, D. S., Sullivan, A. B., & Rensel, M. (2024). Health, Wellness, and the Effect of Comorbidities on the Multiple Sclerosis Disease Course: Tackling the Modifiable. Neurologic Clinics, 42(1), 229-253.
Nasr, Z., Virupakshaiah, A., Schoeps, V. A., Cherbuin, N., Casper, T. C., Waltz, M., ... & Waubant, E. (2024). Gene-environment interactions and risk of pediatric-onset multiple sclerosis associated with time spent outdoors. Multiple Sclerosis and Related Disorders, 82, 105351.
Ziaei, A., Solomon, O., Casper, T. C., Waltz, M., Weinstock-Guttman, B., Aaen, G., ... & Waubant, E. (2024). Gene–environment interactions: Epstein–Barr virus infection and risk of pediatric-onset multiple sclerosis. Multiple Sclerosis Journal, 13524585231224685.
Virupakshaiah, A., Schoeps, V., Race, J., Waltz, M., Sharayahn, S., Nasr, Z., ... & Waubant, E. (2024, April). Predictors of a Relapsing Course in Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (S7. 008). In Neurology (Vol. 102, No. 17_supplement_1, p. 7130). Hagerstown, MD: Lippincott Williams & Wilkins.
Nasr, Z., Casper, T. C., Waltz, M., Virupakshaiah, A., Lotze, T., Shukla, N., ... & Waubant, E. (2024). Clinical and magnetic resonance imaging outcomes in pediatric-onset MS patients on fingolimod and ocrelizumab. Multiple Sclerosis and Related Disorders, 105647.

Edited Books, Monographs or Journal Volumes

Fast Facts Multiple Sclerosis, M Rensel and Orla Gray, Fourth edition, Health Press, 2016.
Mary R. Rensel Netter MS Clinical Manifestations 2022

Invited, Non-Peer Reviewed.

Rensel MR and Moodley M, Multidisciplinary Approach to Improve Care for Pediatric MS, Neuroscience pathways, fall, 2006.

BP Moss, MR Rensel, CM Hersh.Wellness and the role of comorbidities in multiple sclerosis

Neurotherapeutics 14 (4), 999-1017

Mary R. Rensel, Wellness Journey with Multiple Sclerosis – Where to Start US Neurology. 2018;14(1):31-33 DOI: https://doi.org/10/17925/USN.2...

Book & Book Chapters

The differential diagnosis of MS and clues to Misdiagnosis

Cohen JA and Rensel MR, Multiple Sclerosis; Diagnosis, Medical Management, and Rehabilitation

Burks, JS and Johnson KP, 127-138. 2000

General Health and Wellness in MS

Rensel M

Multiple Sclerosis and Related Disorders

Rae Grant A, Fox, R and Bethoux F, 235-242, 2013

General Health and Wellness in MS

Rensel M, Hersh C Moss B

Multiple Sclerosis and Related Disorders

Rae Grant A, Fox, R and Bethoux F, 235-252, 2018

Health, Wellness and the Effects of Comorbidities on the Multiple Sclerosis Disease Course; Tackling the Modifiable

Devon Conway, Amy B. Sullivan and Mary R Rensel

Multiple Sclerosis, Neurologic Clinics

Randolph E Evans and Carrie M Hersh

Media Appearances & Coverage / Podcasts

MS in Women, MS Across the Reproductive Lifespan, Association of Reproductive Health Professionals, 2/8/2018 , Webinar
MS in Women, Treating MS through the Reproductive Lifespan, Association of Reproductive Health Professionals 1/21/2018 , Webinar
MS in Women, Diagnosis and Treatment, Association of Reproductive Health Professionals 1/11/2018
Wellness Practices That Can Improve Multiple Sclerosis Outcomes
https://consultqd.clevelandcli...; , Print
http://www.everydayhealth.com/... , Print
http://health.usnews.com/healt... , print

A new MS article re: “5 Things You Need to Know About Multiple Sclerosis” is live on Health Hub and can be seen here: http://health.clevelandclinic..... Print
Everydayhealth.com story re: MS and natural remedies. Print http://www.everydayhealth.com/...;
Good Morning America 2012 , TV

http://abcnews.go.com/GMA/vide...;

WKYC: http://www.wkyc.com/news/story... , TV
Cleveland Jewish News: Making an inconvenience convenient: Cleveland Clinic brings specialized MS, print.
Cleveland Zocor and MS 10/11/2012:
http://www.everydayhealth.com/...;
Travel and MS 11/2012:

http://www.everydayhealth.com/...;

Managing MS symptoms on AOL Health
http://www.everydayhealth.com/...
grid7%7Cmaing7%7Cdl29%7Csec3_lnk3%26pLid%3D261407#/slide-1 http://www.medscape.com/viewar...;
MS and the death of Annette Funichello

http://health.clevelandclinic....;

What’s new in MRI imaging for MS, summary of Consortium of Multiple Sclerosis Centers meeting’s findings, Cleveland Clinic CME, 6/25/2015
The Need for prognostic indicators for Pediatric MS https://www.neurologylive.com/...
https://www.healthcentral.com/...
https://www.medscape.com/viewa... Medscape Shared Medical Appointments Educate, Encourage MS Patients

Podcasts

Growth Edge Podcast, Brain Health, November 2019
Imagine That! With Miriam Franco , Pediatric Multiple Sclerosis, October 2019
Need to Know with Sam and John, Multiple Sclerosis Advocacy, October 2019
MSAA Wellness in MS March 2020
WPSA Insights and Inspirations 2021- 2023
https://awomanshealth.com/heal...

Letter

Waubant, E., Amezcua, L., Sicotte, N., Hellwig, K., Krupp, L., Weinstock-Guttman, B., Yeh, A., Lucas, R.M., Longbrake, E.E., Yadav, V. and Rensel, M., 2018. Gender inequities in the multiple sclerosis community: A call for action.

Abstract Presentations

Shields, RW M.D., Rensel, MR M.D. and Wilbourn, AJ M.D. Compressive Deep Peroneal Mononeuropathies in a Telephone Lineman,Muscle and Nerve Vol.17,No.9,Sept 1994,1109.
Rensel, M M.D., Levin, KH M.D. The Influence of Electrodiagnosis of Carpal Tunnel Syndrome on Treatment, Muscle and Nerve Vol.17,No.9,Sept.1994,1112
Rensel, MR M.D., Sila, CA M.D., Frank, J M.D., Masaryk, TM.D., Wallace R ,M.D., Furlan, A M.D., and Hanna, J M.D. Current Management of Symptomatic Vertebrobasilar Stenosis.Neurology 46 Vol 46,Num 2, Feb 1996.A256
Rensel, MR M.D., Sila, CAM.D. The Utility of the MRA in Diagnosing Basilar Artery Stenosis After a Lacunar Syndrome,Stroke Vol.28.No1 Jan. 1997,252
Abou-Chebl, A., Rensel, M.R., Sila, C.A. and Krieger, D.W., 2000, January. Longterm outcome in symptomatic intracranial vertebrobasilar occlusive disease. In Stroke (Vol. 31, No. 1, pp. 294-294). 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA: LIPPINCOTT WILLIAMS & WILKINS.
MR Rensel, RP Kinkel, M Secic Oral methotrexate dose-escalation study in progressive multiple sclerosis Annals of Neurology 42 (3), M121-M121 1997
Rensel M, Weinstock-Guttman B, Rudick R. Devic’s disease: Diagnostic and therapeutic challenge. Multiple Sclerosis Journal. 1997;3(6):408-408. doi:10.1177/135245859700300621
Primary chronic progressive myelopathy: Disease features and relationship to MS MR Rensel, B Weinstock-Guttman, R Rudick .Neurology 50 (4), A209-A209 1998
Rensel M., Cohen J, Kinkel R. P. ,Ransohoff R. , Rudick R and Witherspoon H. Tolerability and Effectiveness of Monthly Cyclophosphamide and Methylprednisolone Pulses in MS Patients Who Deteriorate Despite Standard Therapy, Neurology 52 Apr 1999(Suppl 2). A497.
Clinical experience with plasma exchange for severe relapse in patients with Devic's disease. MR Rensel, B Weinstock-Guttman, R Kinkel, R Rudick, L Jacobs Neurology 54 (7), A23-A23 2000
Weinstock-Guttman, B., Baier, M., LeeKwen, P., Feichter, J., Dinehart, S., Venkatraman, J., Meksawan, K., Rensel, M., Bochiechio, P., Brownscheidle, C. and Munschauer, F., 2002, April. A randomized study of low-fat diet with omega-3 fatty acid supplementation in patients with relapsing-remitting multiple sclerosis (RRMS). In Neurology (Vol. 58, No. 7, pp. A461-A462). 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA: LIPPINCOTT WILLIAMS & WILKINS.
Stone, L. A., E. Fisher, A. Das, R. A. Rudick, J. Cohen, R. Finkel, M. Rensel et al. "The routine use of quantitative MRI data in a multiple sclerosis center." In Neurology, vol. 54, no. 7, pp. A119-A119. 2000.
Schuele S, Tavee J, Rensel MR, Sweeney P, Parkinsonism responsive to plasmapheresis in a case of MS, 7Th International Movement Disorder Congress, 11/2002
Rubina S, Lang D, Rensel M, Hsieh F and Radjocic C. Management of Glatiramer Reactions: Experience with Desensitization,American Academy of Allergy, Asthma and Immunology,Journal of Allergy and Clinical Immunology supplement 02/2004
B Banwell 1,2, J Kennedy 1, L Krupp 3, A Bar-Or 4, S Tenembaum 5, A Belman 3, J Ness 6 , J Hahn 7, E

Waubant 8, J Mah 9, M Rensel 10 , K Farrell 11, MFreedman 12, V Bhan 13, M Dilenge 14, M Ruggieri 15, M Iivanainen 16 B Weinstock-Guttman 17 Clinical and demographic features of pediatric multiple sclerosis: Preliminary data from a multinational collaborative study. Neurology supplement 04/2004

MR Rensel, D Miller PhD. American Academy of Neurology 4/2005, Pediatric MS: Long term Vocational Data,Neurology 64 March 2005(Suppl 1)A322
B Banwell 1,2, J Kennedy 1, L Krupp 3, A Bar-Or 4, S Tenembaum 5, A Belman 3, J Ness 6 , J Hahn 7, E Waubant 8, J Mah 9, M Rensel 10 , K Farrell 11, MFreedman 12, V Bhan 13, M Dilenge 14, M Ruggieri 15, M Iivanainen 16 B Weinstock-Guttman , Clinical and demographic features of pediatric multiple sclerosis:
Preliminary data from a multinational collaborative study 17Neurology 64 March 2005(Suppl 1)
Dr. C. Lopez-Amaya, Toronto, Ontario, Canada, Dr. K. O’Connor, Boston Massachusetts, United States, Ms. L. Kopel, Montreal, Quebec, Canada, Dr. R. Fattahie, Montreal, Quebec, Canada, Ms. N. Moore, Boston Massachusetts, United States, Mr. D. Gano, Montreal, Quebec, Canada, Dr. A. Fournier, Montreal, Quebec, Canada, Dr. M. Moscarello, Toronto, Ontario, Canada, Dr. B. Banwell, Toronto, Ontario, Canada, Ms. J.
Kennedy, Toronto, Ontario, Canada, Dr. L. Krupp , Stony Brook, New York, United States, Dr. S. Tenembaum, Buenos Aires, Argentina, Dr. A. Boiko, Moscow, Russian Federation, Dr. O. Bykova, Moscow, Russian Federation, Dr. A. Belman, Stony Brook, New York, United States, J. Mah, Calgary, Alberta, Canada, Dr. C.
Stoian, Calgary, Alberta, Canada, Dr. J. Ness, Birmingham, Alabama, United States, Dr. M. Rensel, Cleveland, Ohio, United States, Dr. J. Hahn, Stanford, California, United States, Dr. B. Weinstock-Guttman, Buffalo, New York, United States, Dr. A. Yeh, Buffalo, New York, United States, Dr. E. Waubant, San Francisco, California, United States, Dr. K. Farrell, Vancouver, British Columbia, Canada, Dr. M. Freedman, Ottawa, Ontario, Canada, Dr. V. Bhan, Halifax, Nova Scotia, Canada, Dr. M. Dilenge, Montreal, Quebec, Canada, Dr. M. Iivanainen, Helsinki, Finland, Dr. M. Kremenchutzky, London, Ontario, Canada, Dr. M. Ruggieri, Catania, Italy and Dr. A. Bar-Or, Montreal, Quebec, Canada, Anti-myelin antibodies in pediatric Ms. AAN 4/05, Neurology 64 March 2005(Suppl 1)
B Banwell, R Tellier, L Krupp, A Bar-Or, J Kennedy, S Tenembaum,A Boiko, O Bykova, A Belman, J Mah, C Stoian, J Ness, M Rensel, J Hahn, BWeinstock-Guttman, A Yeh, E Waubant, K Farrell, M Freedman, V Bhan, M Dilenge, M Iivanainen, M Kremenchutzky, M Ruggieri, Viral exposures in pediatric multiple sclerosis: Preliminary data from a multinational collaborative study. To be presented at AAN 4/05 Neurology 64 March 2005(Suppl 1) A319 and Presented ECTRIMS 10/04
Rensel M. The International Pediatric MS Study Group, S52.001, Consensus Definitions of Acquired CNS Demyelinating Disorders Of Childhood, Neurology 66 March 2006 ( Suppl 2) A380
Rensel M, Weinstock-Guttman B, Rudick R, Kinkel R. Clinical Experience with Plasma Exchange for Severe Relapse in Patients with Devic’s Disease, Neurology Vol. 54,Suppl 3 April 2000 No 7. A23.
Tripathy A, Rensel M and Moodley M, Childhood MS, Center Based analysis of 22 cases, NEUROLOGY 70 (11), A133-A133 2008
Tripathy AK, Rensel M, Moodley M, Childhood MS-The Cleveland Clinic Experience, Annals of Neurol Vol64 Suppl 12. S109 2008
A McKeon, V Lennon, T Lotze, S Tenembaum, J Ness, M Rensel, N Kuntz. CNS aquaporin-4 autoimmunity in childhood .NEUROLOGY 70 (11), A419-A420 2008
Pediatric Neuromyelitis Optica and NMO Antibody .NM Le, M Rensel, J Bena, M Moodley .ANNALS OF NEUROLOGY 66, S61-S61 2009
Neuromyelitis optica: disease onset in relationship with infections and vaccinations .NM Le, D Ontaneda, M Moodley, S Worley, M Rensel Journal of Neurology 256, S54-S54 2009
J Tavee, M Rensel, S Planchard and L Stone. Effects of Meditation on Pain and Quality of Life in MS and PN: A Controlled study, Neurology 74 March 2,2010 Suppl 2
B Weinstock-Guttman, M Baier, P LeeKwen, J Feichter, S Dinehart, RenselM A randomized study of low-fat diet with omega-3 fatty acid supplementation in patients with relapsing-remitting multiple sclerosis (RRMS) Neurology 58 (7), A461-A462 ,2010.
Rensel, MR M.D., Shields, RW M.D., Prayson, RM.D. The Spectrum of Clinical and Electrodiagnostic Features in Amyloid Neuropathy, Muscle and Nerve Vol.19, No.9 pp 1219, 2010
Christine S Moravec, Michael G McKee, James B Young, Betul Hatipoglu, Leopoldo Pozuelo, Leslie Cho, Gordon Blackburn, Francois Bethoux, Mary Rensel, Katherine Hoercher, J Javier Provencio, Marc S Penn "Multidisciplinary Research in Biofeedback." Cleveland Clinic Journal of Medicine 77, no. Suppl 3 (2010): S85a-S85a. 2010
Abboud, Hesham, Mary Rensel, Carrie Hersh, Srivadee Oravivattanakul, Mayur Pandya, and Anwar Ahmed. "Coexisting Multiple Sclerosis and Huntington’s Disease: Reflections on the Immune Theory in Neurodegenerative Disorders." 2014
Matt Baumann, Dana L Frank, Michael Liebenstein, Jerry Kiffer, Leo Pozuelo, Leslie Cho, Gordon Blackburn,
Francois Bethoux, Mary Rensel, Betul Hatipoglu, Jim Young, Christine S Moravec, Michael G McKee

Biofeedback in Coronary Artery Disease, Type 2 Diabetes, and Multiple Sclerosis. Cleveland Clinic Journal of Medicine, 78(Suppl 1), S80-S80.2011

Ian Rossman, Mary Rensel. An 8 Year Old Girl with Chronic Inflammatory Optic Neuritis (CRION): the Youngest Reported Case, American Academy of Neurology 04/2015, Neurology 84 (14 Supplement), P7. 015
Mary Rensel, Youran Fan and Suji Baskar. Association of Wellness practices in MS patients using self-reported disability scores and MS characteristics, American Academy of Neurology 04/2015, Neurology 84 (14 Supplement), P3. 229
Rensel, M Et al, Engaging Women Staff at Cleveland Clinic Patient Experience Summit Cleveland, OH April, 2015
Sullivan A, Rensel, M, Hersh, C Women in Neurology: Lessons Learned and Lessons Still Learning CMSC May 2016
Obtaining Patient and Family Views in Pediatric MS Research Needs, Outcomes and Methods: Study Design (P2. 129), T Chitnis, D Rintell, E O'Donnell, T Lotze, B Weinstock-Guttman, Rensel M, Neurology 86 (16 Supplement), P2. 129 2016
NEDA in Pediatric MS, Is It Attainable? (P2. 128) M Rensel, I Rossman, M Moodley, Neurology 86 (16 Supplement), P2. 128 2016
Dimethyl Fumarate Is Well Tolerated in a Small Cohort of Pediatric-Onset Multiple Sclerosis Patients (P3.

010), I Rossman, M Moodley, M Rensel, Neurology 86 (16 Supplement), P3. 010 2016

Pediatric Onset Multiple Sclerosis: A Single Center Experience,E Yamamoto, M Ginsberg, M Rensel, M Moodley, ANNALS OF NEUROLOGY 80, S332-S332, 2016
Carolyn E. Schwartz, Sc.D., et al.., Stephanie AGrover, M.S., Victoria E. Powell, M.P.H., Austin Noguera, Jean K. Mah, M.D., M.Sc., Soe Mar, M.D., Lauren MednickM.D., Brenda L. Banwell, M.D Gulay Alper, M.D. , Mary Rensel, M.D. , Mark Gorman, M.D., Amy Waldman, M.D. , Teri Schreiner, M.D., Emmanuelle Waubant, M.D., E. Ann Yeh, M.D. Medication Adherence in Pediatric MS: Barriers and Facilitators, 2016.
I Rossman, M Moodley, M Rensel, NEDA is Rare in Pediatric Onset MS treatment. Can We Do Better with Higher Potency Disease Modifying Therapies? ANNALS OF NEUROLOGY 80, S332-S332 , 2016
M. Rensel. Risk factors for non-adherence to disease-modifying therapy in pediatric multiple sclerosis" has been accepted for a poster presentation at the American Academy of Neurology 69th Annual Meeting, April 22 to April 28, 2017 in Boston, MA.
Factors associated with Pediatric Onset Multiple Sclerosis slowed gait, does mood matter? (P1. 355)

Bauer, H Li, M Rensel, Neurology 88 (16 Supplement), P1. 355, 2017

Chitnis, Tanuja, Tanuja Chitnis, David Rintell, Ellen O'Donnell, Timothy Lotze, Bianca Weinstock-Guttman, Emmanuelle Waubant, Anita Belman, Gregory Aaen, Leslie Benson, Mark Gorman, Jennifer Graves, Soe Mar, Manikum Moodley, Jayne Ness, Mary Rensel, Moses Rodriguez, Teri Schreiner, Jan-Mendelt Tillema, John Rose, Charlie Casper. "Obtaining Patient and Family Views in Pediatric MS Research Needs, Outcomes and Methods: Study Design (P2. 129)." Neurology 86.16 Supplement (2016): P2-129.
Smith, Andrew L., Mary Rensel, and Daniel D. Ontaneda. "Post pregnancy outcome in relapsing remitting MS based off of Anesthesia choice for labor and delivery." MULTIPLE SCLEROSIS JOURNAL. Vol. 23. No. 1. 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND: SAGE PUBLICATIONS LTD, 2017.
Schwarz, Carolyn, Rensel M. "Risk factors for non-adherence to disease-modifying therapy in pediatric multiple sclerosis (P1. 349)." Neurology 88.16 Supplement (2017): P1-349.
Amy Lavery, Amy Waldman, Shelly Roalstad, TC Casper, J Ness, Mark Gorman, Leslie Benson, Bianca, Weinstock-Gutman, JE Rubin, Teri Schreiner, G Aaen, JM Tillema, Moses Rodriguez, Tanuja Chitnis, Meghan Candee, Lauren Krupp, A Belman, T Lotze, Jennifer S Graves, Benjamin Greenberg, S Mar, John Rose, Manikum Moodley, Manu Goyal, Mary Rensel, Y Harris, I Kahn, Emmanuelle Waubant Poor air quality is associated with increased counts of pediatric MS MULTIPLE SCLEROSIS JOURNAL 23 (1), 37-38 , 2017
Bauer, C., Li, H. and Rensel, M., 2017, October. Depression and physical performance in pediatric onset MS patients. In MULTIPLE SCLEROSIS JOURNAL (Vol. 23, pp. 700-701). 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND: SAGE PUBLICATIONS LTD.
Early age of onset predicts severity of visual impairment in patients with neuromyelitis optica,G. Macaron1, H. Li2, M. Seay3, J. Cohen1, M. Rensel,
Patterns of Use and Safety of Newer Disease-modifying therapies in Pediatric Multiple Sclerosis in the US (S51.004). Kristen Krysko, Jennifer Graves, Mary Rensel, Gregory Aaen, Leslie Benson, Tanuja Chitnis, Mark Gorman, Manu Goyal, Yolanda Harris, Lauren Krupp, Timothy Lotze, Soe Mar, Manikum Moodley, Moses Rodriguez, John Rose, Teri Schreiner, Bianca Weinstock-Guttman, Michael Waltz, T. Charles Casper, Emmanuelle Waubant, Neurology Apr 2018, 90 (15 Supplement) S51.004.
Spurgeon, Elizabeth, Justin Abbatemarco, and Mary Rensel. "A Case of Severe Legionella Pneumonia following the Second Treatment Course of Alemtuzumab Infusion for Relapsing Remitting Multiple Sclerosis , (P5. 352)." (2018): P5-352.
Krysko, K. M., Graves, J., Rensel, M., Weinstock-Guttman, B., Aaen, G., Benson, L., & Lotze, T. (2018). Use of newer disease-modifying therapies in pediatric multiple sclerosis in the US. Neurology, 91(19), e1778-e1787.
Predicting Employment Disability and Living with Assistance Using Neuroperformance and

Quantitative MRI in Multiple Sclerosis, Mellen Center, American Congress of Treatment and Research, Dallas, TX 2019

Comprehensive Assessments in Clinic Using Technology-Enabled Multiple Sclerosis Functional Composite-4, Patient Reported Outcomes, and Advanced MRI, Mellen Center, ACTRIMS. Dallas, TX 2019
Cross-Sectional Predictive Value of Clinically Meaningful Change in Processing Speed on Self-Reported

Cognition and MRI Metrics, Mellen Center, American Congress of Treatment and Research. Dallas, TX 2019

Predicting Employment Disability and Living with Assistance using Neuroperformance and Quantitative MRI in Multiple Sclerosis, Mellen Center, American Congress of Treatment and Research in MS, ACTRIMS. Dallas, TX 2019
Quantitative MRI and Patient reported outcomes validate clinically meaningful Differences on Tests of

Ambulation and Hand Function, Mellen Center, American Congress of Treatment and Research in MS,

ACTRIMS. Dallas, TX 2019

Family History of Autoimmune Disorders Among Pediatric Multiple Sclerosis Patients Network of Ped MS

Centers, American Congress of Treatment and Research in MS, ACTRIMS Dallas, TX 2019

Distribution and predictors of disease severity in pediatric multiple sclerosis Investigate the distribution of

Disease severity in pediatric-onset multiple sclerosis (MS).” Platform presentation at the American Academy of Neurology 71st Annual Meeting, May 4 to May 10, 2019 in Philadelphia, PA.

Cognitive processing speed in early pediatric onset MS: baseline features and predictors of decline Lauren

Krupp, Asya Wallach, Michael Waltz, Charles Casper, Gregory Aaen, Antita Belman, Leslie Benson, Tanuja Chitnis, Mark Gorman, Jennifer Graves, Yolanda Harris, Timothy Lotze, Soe Mar, Manikum Moodley, Jayne Ness, Mary Rensel, Moses Rodriguez, John Rose, Terri Schreiner, Jan-Menndelt Tillema, Emmanuelle Waubant, Bianca Weinstock-Guttman, Leigh Charvet, on behalf of the US Network of Pediatric Multiple Sclerosis Centers, ECTRIMS Sweden 2019 MULTIPLE SCLEROSIS JOURNAL (Vol. 25, pp. 98-99). 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND: SAGE PUBLICATIONS LTD.

Real-world effectiveness of first-line newer versus injectable disease-modifying therapies in pediatric multiple sclerosis in the US, Kristen M Krysko, Jennifer S Graves, Mary Rensel, Bianca Weinstock-Guttman, Alice Rutatangwa, Gregory Aaen, Anita Belman, Leslie Benson, Tanuja Chitnis, Mark Gorman, Manu Goyal, Yolanda Harris, Lauren Krupp, Timothy Lotze, Soe Mar, Manikum Moodley, Jayne Ness, Moses Rodriguez, John Rose, Teri Schreiner, Jan-Mendelt Tillema, Michael Waltz, T. Charles Casper, and Emmanuelle Waubant, ECTRIMS Sweden 2019
Poor visual outcome in neuromyelitis optica is associated with early disease onset and use of first-line oral therapy, Gabrielle Macaron, MD1, Jean Khoury, MD2, James Bena3, Jeffrey A. Cohen, MD1, Mary Rensel, ECTRIMS Sweden 2019 MULTIPLE SCLEROSIS JOURNAL 2019 Sep 1 (Vol. 25, pp. 143-143)
The contribution of white matter lesions to whole brain and deep grey matter atrophy in patients with MS (S31.001). Kedar Mahajan, Kunio Nakamura, Jenny Feng, Gabrielle Macaron, Brandon Moss, Marisa McGinley, Hong Li, Stephen Jones, Mark Lowe, Adrienne Boissy, Devon Conway, Robert Fox, Alexander Rae-Grant, Mary Rensel, Mary Willis, Robert Bermel, Jeffrey Cohen, Daniel Ontaneda. Neurology Apr 2019, 92 (15 Supplement) S31.001; AAN
Improved Multiple Sclerosis Management Using Shared Medical Appointments- A Single Center Experience. Abbatamarco J Rensel M ACTRIMS 2020 West Palm Beach, Fl Feb 2020
Processing Speed Test Performance in Pediatric Versus Adult onset MS Conway D Rensel M ACTRIMS 2020 West Palm Beach, Fl Feb 2020
Real World Effectivess of Initial Treatment with Newer Versus Injectable Disease Modifying therapies in Pediatric MS Network of Pediatric MS ACTRIMS 2020 West Palm Beach, Fl Feb 2020
Unique Features of Pediatric Onset MS as Compared to Adult Onset MS in a large Cohort Planchon Rensel M ACTRIMS 2020 West Palm Beach, Fl Feb 2020
Upper and Lower Extremity Function in Pediatric onset verse Adult onset MS ACTRIMS 2020 West Palm Beach, Fl Feb 2020
Familial History of Autoimmune Disorders Among Patients With Pediatric Multiple Sclerosis

Benjamin M. Greenberg, Theron Charles Casper, Soe S. Mar, Jayne M. Ness, Patricia Plumb, Shannon Liang, Manu Goyal, Bianca Weinstock-Guttman, Moses Rodriguez, Gregory S. Aaen, Anita Belman, Lisa F. Barcellos, John W. Rose, Mark P. Gorman, Leslie A. Benson, Meghan Candee, Tanuja Chitnis, Yolanda C. Harris, Ilana L. Kahn, Shelly Roalstad, Janace Hart, Timothy E. Lotze, Mary Rensel, Jennifer P. Rubin, Teri L. Schreiner, Jan-Mendelt Tillema, Amy Tara Waldman, Lauren Krupp, Jennifer Graves, Kaylea Drake, Emmanuelle Waubant, Neurol Neuroimmunol Neuroinflamm Sep 2021, 8 (5) e1049; DOI: 10.1212/NXI.0000000000001049

A Retrospective Chart Review of the Safety and Tolerability in Ocrelizumab in Pediatric and Young-Adult Onset Multiple Sclerosis (4568),Carolyn Goldschmidt, Mary Rensel, Kedar Mahajan, Moein Amin

Neurology Apr 2020, 94 (15 Supplement) 4568;

Menarche and relapse in girls with MS, Krysko, Kristen M.; Waltz, Michael; Chitnis, Tanuja; Weinstock-Guttman, Bianca; Aaen, Greg; Benson, Leslie; Gorman, Mark; Harris, Yolanda; Krupp, Lauren B.; Lotze, Timothy; Mar, Soe; Moodley, Manikum; Ness, Jayne; Rensel, Mary; Rodriguez, Moses; Rose, John; Rutatangwa, Alice; Schreiner, Teri; Waubant, Emmanuelle; Casper, T. Charles International Journal of MS Care . 2020, Vol. 22 Issue S2, p1-1. 1/2p.
Demographic and Clinical Profile of Pediatric patients with Multiple Sclerosis Infected with SARS-Cov2 (4351) Teri Schreiner, Molly Wilson- Murphy, Tanuja Chitnis, Leslie Benson, Mark Gorman, Lauren Krupp, Timothy Lotze, Soe Mar, Jayne Ness, Mary Rensel, Moses Rodriguez, Nikita Shukla, Emmanuelle Waubant, John Rose, Justin Wheeler, Michael Waltz, Shelly Roalstad, Theron Casper Neurology Apr 2021, 96 (15 Supplement) 4351; AAN Virtual
Analysis of Gender Representation Among Physician Authors in American Academy of Neurology Clinical Practice Guidelines (2204)Lindsay Ross, Rachael Mathew, Gabriella Bal, Peter Brown, Elizabeth Spurgeon, Catherine Hassett, Mary Rensel, Julie Silver, Neurology Apr 2021, 96 (15 Supplement) 2204;
Unique Patterns of Comorbidities in Pediatric Onset vs. Adult Onset Multiple Sclerosis Using a Large Real-world MS Population (2287) Mary Rensel, Devon Conway, Sarah Planchon Pope, Neurology Apr 2021, 96 (15 Supplement) 2287; AAN Virtual
Umeton, R., et al. "Therapeutic response in pediatric neuromyelitis optics spectrum disorder." MULTIPLE SCLEROSIS JOURNAL. Vol. 26. No. 3_ SUPPL. 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND: SAGE PUBLICATIONS LTD, 2020.
Ziaei, A., et al. "Evidence for an interaction between ozone pollution and HLA-DRB1 (star) 15 alleles in pediatric multiple sclerosis Impact of the environment and lifestyle and MS risk and clinical course." MULTIPLE SCLEROSIS JOURNAL. Vol. 26. No. 3_ SUPPL. 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND: SAGE PUBLICATIONS LTD, 2020.
A survey-based study of the impact of the COVID-19 pandemic in patient with neuromyelitis optica spectrum disorder. Goldschmidt, C.; Mahadeen, A.; Rensel, M.Multiple Sclerosis Journal ; 27(2 SUPPL):168-169, 2021.Artigo em Inglês | EMBASE | ID: covidwho-1495996
Feng, J., et al. "Assessing no evidence of disease activity in pediatric onset multiple sclerosis." MULTIPLE SCLEROSIS JOURNAL. Vol. 26. No. 3_ SUPPL. 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND: SAGE PUBLICATIONS LTD, 2020.
Rutatangwa, A., et al. "Characteristics And Predictors Of Disease Course In Children Initially Presenting With ADEM." MULTIPLE SCLEROSIS JOURNAL. Vol. 26. No. 1_ SUPPL. 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND: SAGE PUBLICATIONS LTD, 2020.
Unique patterns of Comorbidities in Pediatric vs Adult onset MS Using Real world data, Rensel M, Planchon, and Conway. AAN 2021
Wendy M Coronado1, Sarah Planchon, PhD2, Devon S Conway, MD, MSc2, Marisa McGinley, DO, MSc2, Mary Rensel, MD21Fatigue Scores are Better in Pediatric Onset Multiple Sclerosis than Adult Onset Multiple Sclerosis. Ectrims Global Virtual 2021
Coronado, W. M., Planchon, S., Conway, D. S., Amin, M., & Rensel, M. (2021, October). Pediatric Onset Multiple Sclerosis: Neuro-Performance Testing, MRI Metrics, and Quality of Life Measures. In ANNALS OF NEUROLOGY (Vol. 90, pp. S177-S177). 111 RIVER ST, HOBOKEN 07030-5774, NJ USA: WILEY., presented at ANA virtually, Chicago, Il October, 2021
Association of Neurofilament Light Chain with Disease Activity in Pediatric Onset Multiple Sclerosis. M. Amin, e, Conway C, Planchon S, Rensel ACTRIMS 2022 West Palm , Fl
Pediatric-onset MOGAD is Not Associated with DRB1*15. Amin Ziaei1, Soe Mar2 , Eoin P.Flanagan3, T. Charles Casper4 , Carla Francisco1 , Alice Rutatangwa1 , Meghan Candee4, John Rose4, Anita Belman5, Bianca Weinstock-Guttman6, Greg Aaen7, Jennifer Graves8, Jan-Mendelt Tillema3, Moses Rodriguez3, Jayne Ness9, Yolanda Harris9, Lauren Krupp10, Leslie Benson11, Mark Gorman11 , Manikum Moodley12, Mary Rensel13, Manu Goyal14, Amy T. Waldman14, Tanuja Chitnis15, Teri Schreiner16, Tim Lotze17, Benjamin Greenberg18, Janace Hart1 , Lisa F. Barcellos19 & Emmanuelle Waubant1, on behalf of the US Network of Pediatric MS Centres, ACTRIMS 2022, West Plam, Florida
Chizmadia, D., Rose, D., Stack, J., Liriano, A., Glaser, J. and Rensel, M., 2022. B-Cell therapy Shared Medical Appointments (BCSMA) lead to faster time to treatment and less indirect care (P16-7.004).
Rensel, King, Boyle, Perez-Perotto, Pappas. Developing an academic based podcast exploring the highlights and challenges of being a woman in medicine with the long term goal of gender parity and empowerment of women leadership in academic medicine, Women in Medicine Summit 2022, Chicago, IL
Clinical Outcomes of COVID-19 Infection Among Patients with NMOSD Receiving Inebilizumab Treatment in the N-MOmentum Trial and Safety Database in the United States. Bruce AC Cree,1 Mary Rensel,Sean Pittock,Aram Zabeti,Ho-Jin Kim, Friedemann Paul, Derrick Robertson, Kristina Patterson, Qing Li, Quinn Dinh, Michael Levy
Race and Social Determinants of Health in Performance Outcomes among Relapsing Remitting Multiple Sclerosis Patients American Academy of Neurology, Boston, MA, April 2023
Clinical Out Clinical Outcomes of COVID-19 Infection Among Patients with NMOSD Receiving Inebilizumab Treatment in the N-MOmentum Trial and Safety Database in the United States. Claudia Bonetto,1 Bruce AC Cree,2 Mary Rensel,3 Sean Pittock,4 Aram Zabeti,5 Ho-Jin Kim,6 Friedemann Paul,7 Derrick Robertson,8 Kristina Patterson,9 Qing Li,9 Quinn Dinh,9 Michael Levy10. Societá Italiana di Neurologia congress taking place october 21-24 in Napoli, Italy
Barney, B., Peterson, S., Waltz, M., Wright, M., Rose, J., Rensel, M., ... & Casper, T. (2024, April). Evaluating the Use and Efficacy of Avonex and Plegridy in Pediatric Patients (P11-6.005). In Neurology (Vol. 102, No. 17_supplement_1, p. 6412). Hagerstown, MD: Lippincott Williams & Wilkins.
Abrams, A., Peterson, S., Race, J., Virupakshaiah, A., O'Neill, K., Gambrah-Lyles, C., ... & Rose, J. (2024, April). Pediatric to Adult MS Transition Practices in the US (P1-6.007). In Neurology (Vol. 102, No. 17_supplement_1, p. 6051). Hagerstown, MD: Lippincott Williams & Wilkins.